日本医師会医学研究奨励賞

2019.11   日本医師会  

福岡医学会総会一般演題優秀賞

2019.2   福岡県医師会  

日本肝臓学会研究奨励賞

2018.6   日本肝臓学会  

日本外科学会研究奨励賞

2013.4   日本外科学会  

Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial Reviewed International journal

Kayashima H, Itoh S*, Shimokawa M, Hayashi H, Takamori H, Fukuzawa K, Ninomiya M, Araki K, Yamashita Y-i, Sugimachi K, Uchiyama H, Morine Y, Utsunomiya T, Uwagawa T, Maeda T, Baba H, Yoshizumi T

Int J Clin Oncol.   28 ( 11 )   1520 - 1529   2023.11

Effect of Early Enteral Nutrition on Graft Loss After Living Donor Liver Transplantation: A Propensity Score Matching Analysis Reviewed International journal

Tomino T, Harada N, Toshida K, Tomiyama T, Kosai Y, Kurihara T, Yoshiya S, Takeishi K, Toshima T, Nagao Y, Morita K, Iguchi T, Itoh S, Yoshizumi T

Transplant Proc.   55 ( 9 )   2164 - 2170   2023.9

Transferrin Receptor is Associated with Sensitivity to Ferroptosis Inducers in Hepatocellular Carcinoma Reviewed International journal

Hiromatsu M, Toshida K, Itoh S*, Harada N, Kohashi K, Oda Y, Yoshizumi T

Ann Surg Oncol.   30 ( 13 )   8675 - 8689   2023.9

Preoperative HALP score is a prognostic factor for intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection: association with sarcopenia and immune microenvironment Reviewed International journal

Toshida K, Itoh S*, Nakayama Y, Tsutsui Y, Kosai-Fujimoto Y, Tomino T, Yoshiya S, Nagao Y, Harada N, Kohashi K, Oda Y, Yoshizumi T

Int J Clin Oncol.   28 ( 8 )   1082 - 1091   2023.8

Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer Reviewed International journal

Umemoto K, Sunakawa Y, Ueno M, Furukawa M, Mizuno N, Sudo K, Kawamoto Y, Kajiwara T, Ohtsubo K, Okano N, Matsuhashi N, Itoh S, Matsumoto T, Shimizu S, Otsuru T, Hasegawa H, Okuyama H, Ohama H, Moriwaki T, Ohta T, Odegaard JI, Nakamura Y, Bando H, Yoshino T, Ikeda M, Morizane C

Br J Cancer   128 ( 8 )   1603 - 1608   2023.8

Clinical association between intraoperative ICG fluorescence imaging pattern, preoperative Gd-EOB-DTPA-enhanced MRI findings and histological differentiation in hepatocellular carcinoma Reviewed International journal

TominoT, Itoh S*, Fujita N, Okamoto D, Nakayama Y, Toshida K, Tomiyama T, Tsutsui Y, Kosai Y, Kuri

Hepatol Res.   53 ( 8 )   723 - 736   2023.8

The hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for Child-Pugh A patients undergoing curative hepatic resection for single and small hepatocellular carcinoma Reviewed International journal

Toshida K, Itoh S*, Kayashima H, Nagao Y, Yoshiya S, Tomino T, Fujimoto YK, Tsutsui Y, Nakayama Y, Harada N, Yoshizumi T

Hepatol Res.   53 ( 6 )   522 - 530   2023.6

Clinical Significance of Signal Regulatory Protein Alpha (SIRPα) Expression in Hepatocellular Carcinoma Reviewed International journal

30 ( 6 )   3378 - 3389   2023.6

Prognostic significance for recurrence of FGFR2 in intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection Reviewed International journal

Toshida K, Itoh S*, Yugawa K, Kosai Y, Tomino T, Yoshiya S, Nagao Y, Kayashima H, Harada N, Kohashi K, Oda Y, Yoshizumi T

Hepatol Res.   53 ( 5 )   432 - 439   2023.5

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients Reviewed International journal

Tomiyama T, Suzuki R, Harada N, Tamura T, Toshida K, Kosai-Fujimoto Y, Tomino T, Yoshiya S, Nagao Y, Takeishi K, Itoh S, Kobayashi N, Ito H, Yoshio S, Kanto T, Yoshizumi T, Fukuhara T

Front Cell Infect Microbiol.   13   1197349   2023.5

Textbook outcome in the laparoscopic cholecystectomy of acute cholecystitis Reviewed International journal

Iseda N, Iguchi T, Itoh S*, Sasaki S, Honboh T, Yoshizumi T, Sadanaga N, Matsuura H

Asian J Endosc Surg.   16 ( 4 )   741 - 746   2023.4

Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma Invited Reviewed International journal

Toshida K, Itoh S*, Harada N, Morinaga A, Yugawa K, Tomiyama T, Kosai-Fujimoto Y, Tomino T, Kurihara T, Nagao Y, Morita K, Oda Y, Yoshizumi T

Cancer Sci.   114 ( 3 )   937 - 947   2023.3

Predictive Factors for the Resectable Type of Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplant Reviewed International journal

Kurihara T, Harada N, Morinaga A, Tomiyama T, Toshida K, Kosai Y, Tomino T, Toshima T, Nagao Y, Morita K, Itoh S, Yoshizumi T

Transplant Proc.   55 ( 1 )   191 - 196   2023.1

Preoperative serum brain-derived neurotrophic factor as a predictive biomarker for sepsis after living-donor liver transplantation Reviewed International journal

Tsutsui Y, Yoshio S, Tomiyama T, Shimagaki T, Itoh S, Harada N, Yoshida Y, Yoshikawa S, Kakazu E, Kanto T, Yoshizumi T.

Hepatol Res.   53 ( 1 )   72 - 83   2023.1

Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Reviewed International journal

Niizeki T, Tokunaga T, Takami Y, Wada Y, Harada M, Shibata M, Nakao K, Sasaki R, Hirai F, Shakado S, Yoshizumi T, Itoh S, Yatsuhashi H, Bekki S, Ido A, Mawatari S, Honda K, Sugimoto R, Senju T, Takahashi H, Kuwashiro T, Maeshiro T, Nakamuta M, Aratake Y, Yamashita T, Otsuka Y, Matsumoto S, Sohda T, Shimose S, Murotani K, Tanaka Y.

Target Oncol.   2022.11

Low syntaxin 17 expression in donor liver is associated with poor graft prognosis in recipients of living donor liver transplantation. Reviewed International journal

Tomiyama T, Shimokawa M, Harada N, Toshida K, Morinaga A, Kosai-Fujimoto Y, Tomino T, Kurihara T, Nagao Y, Toshima T, Morita K, Itoh S, Yoshizumi T.

Hepatol Res   2022.10

Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer. Iseda N, Iguchi T, Hirose K, Itoh S, Honboh T, Sadanaga N, Matsuura H. Reviewed International journal

Iseda N, Iguchi T, Hirose K, Itoh S, Honboh T, Sadanaga N, Matsuura H.

Am Surg.   2022.8

Outcomes of living-donor liver transplantation for acute-on-chronic liver failure based on newly proposed criteria in Japan Reviewed International journal

Toshima T, Harada N, Itoh S, Morita K, Nagao Y, Kurihara T, Tomino T, Kosai-Fujimoto Y, Morinaga A, Tomiyama T, Yoshizumi T.

Clin Transplant.   2022.8

Impact of JMJD6 on intrahepatic cholangiocarcinoma. Kosai-Fujimoto Y, Itoh S, Yugawa K, Fukuhara T, Okuzaki D, Toshima T, Harada N, Oda Y, Yoshizumi T, Mori M. Reviewed International journal

Kosai-Fujimoto Y, Itoh S, Yugawa K, Fukuhara T, Okuzaki D, Toshima T, Harada N, Oda Y, Yoshizumi T, Mori M.

Mol Clin Oncol.   2022.7

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients. Reviewed International journal

Toshida K, Itoh S, Tomiyama T, Morinaga A, Kosai Y, Tomino T, Kurihara T, Nagao Y, Morita K, Harada N, Yoshizumi T.

JGH Open   2022.7

Up-regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation. Invited Reviewed International journal

Tomiyama T, Yamamoto T, Takahama S, Toshima T, Itoh S, Harada N, Shimokawa M, Okuzaki D, Mori M, Yoshizumi T.

Hepatol Commun.   2022.6

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma Reviewed International journal

Iseda N, Itoh S, Toshida K, Tomiyama T, Morinaga A, Shimokawa M, Shimagaki T, Wang H, Kurihara T, Toshima T, Nagao Y, Harada N, Yoshizumi T, Mori M.

Cancer Sci.   2022.6

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma Reviewed International journal

Tomiyama T, Itoh S, Iseda N, Toshida K, Morinaga A, Yugawa K, Fujimoto YK, Tomino T, Kurihara T, Nagao Y, Morita K, Harada N, Kohashi K, Oda Y, Mori M, Yoshizumi T.

Oncol Lett.   2022.5

Association between Sarcopenia and Omega-3 Polyunsaturated Fatty Acid in Patients with Hepatocellular Carcinoma Reviewed International journal

Itoh S, Nagao Y, Morita K, Kurihara T, Tomino T, Kosai-Fujimoto Y, Harada N, Fujita N, Ushijima Y, Mori M, Yoshizumi T.

JMA J   2022.4

Impact of Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status Reviewed International journal

Iseda N, Itoh S, Yoshizumi T, Tomiyama T, Morinaga A, Yugawa K, Shimokawa M, Shimagaki T, Wang H, Kurihara T, Kitamura Y, Nagao Y, Toshima T, Harada N, Kohashi K, Baba S, Ishigami K, Oda Y, Mori M.

Hepatol Commun.   2022.4

The ratio of serum des-gamma-carboxy prothrombin to tumor volume as a new biomarker for early recurrence of resected hepatocellular carcinoma Reviewed International journal

Shimagaki T, Yoshizumi T, Itoh S, Iseda N, Tomiyama T, Morinaga A, Wang H, Kurihara T, Nagao Y, Toshima T, Harada N, Kinjo N, Maeda T, Mori M.

Hepatol Res.   2022.4

Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With Pancreatic Ductal Adenocarcinoma Reviewed International journal

Iguchi T, Iseda N, Hirose K, Itoh S, Harada N, Ninomiya M, Sugimachi K, Honboh T, Maeda T, Sadanaga N, Matsuura H.

Am Surg   2022.4

Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection. Reviewed International journal

Itoh S, Tomiyama T, Morinaga A, Kurihara T, Nagao Y, Toshima T, Morita K, Harada N, Mori M, Yoshizumi T.

Ann Gastroenterol Surg.   2022.3

Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response Invited Reviewed International journal

Harimoto N, Itoh S, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Watanabe A, Araki K, Yoshizumi T, Shirabe K.

Anticancer Res.   2022.1

Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 Reviewed International journal

Nakano M, Yatsuhashi H, Bekki S, Takami Y, Tanaka Y, Yoshimaru Y, Honda K, Komorizono Y, Harada M, Shibata M, Sakisaka S, Shakado S, Nagata K, Yoshizumi T, Itoh S, Sohda T, Oeda S, Nakao K, Sasaki R, Yamashita T, Ido A, Mawatari S, Nakamuta M, Aratake Y, Matsumoto S, Maeshiro T, Goto T, Torimura T.

Sci Rep.   2022.1

Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study. Invited Reviewed International journal

Shinji Itoh, Eiji Tsujita, Kengo Fukuzawa, Keishi Sugimachi, Tomohiri Iguchi, Mizuki Ninomiya, Takashi Maeda, Kiyashi Kajiyama, Eisuke Adachi, Hideaki Uchiyama, Tohru Utsunomiya, Yasuharu Ikeda, Soichirou Maekawa, Takeo Toshima, Noboru Harada, Tomoharu Yoshizumi, Masaki Mori

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]   2021.8

Retrospective evaluation of the effect of Ninjin'yoeito in hepatocellular carcinoma patients treated with lenvatinib. Invited Reviewed International journal

Katsuya Toshida, Shinji Itoh, Tomoharu Yoshizumi, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Takeo Toshima, Yoshihiro Nagao, Noboru Harada, Kojiro Hata, Yoko Makihara, Hiroyuki Watanabe, Masaki Mori

Surgery today   2021.8

Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma. Invited Reviewed International journal

Norifumi Iseda, Shinji Itoh, Tomoharu Yoshizumi, Takahiro Tomiyama, Akinari Morinaga, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Takeo Toshima, Yoshihiro Nagao, Noboru Harada, Yoshinao Oda, Masaki Mori

International journal of clinical oncology   2021.7

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma. Invited Reviewed International journal

Shinji Itoh, Tomoharu Yoshizumi, Takahiro Tomiyama, Norifumi Iseda, Akinari Morinaga, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Yoshihiro Nagao, Takeo Toshima, Noboru Harada, Akihiro Nishie, Kousei Ishigami, Masaki Mori

JGH open : an open access journal of gastroenterology and hepatology   5 ( 7 )   785 - 792   2021.7

Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma. Invited Reviewed International journal

Kyohei Yugawa, Shinji Itoh, Tomoharu Yoshizumi, Akinari Morinaga, Norifumi Iseda, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Yoshinao Oda, Masaki Mori

International journal of clinical oncology   2021.6

Impact of Capicua on Pancreatic Cancer Progression Reviewed International journal

Yoshiya, Shohei; Itoh, Shinji; Yoshizumi, Tomoharu; Yugawa, Kyohei; Kurihara, Takeshi; Toshima, Takeo; Harada, Noboru; Hashisako, Mikiko; Yonemasu, Hirotoshi; Fukuzawa, Kengo; Oda, Yoshinao; Mori, Masaki

ANNALS OF SURGICAL ONCOLOGY   28 ( 6 )   3198 - 3207   2021.6

Identification of SLC38A7 as a Prognostic Marker and Potential Therapeutic Target of Lung Squamous Cell Carcinoma. Invited Reviewed International journal

Naoki Haratake, Qingjiang Hu, Tatsuro Okamoto, Tomoko Jogo, Gouji Toyokawa, Fumihiko Kinoshita, Tomoyoshi Takenaka, Tetsuzo Tagawa, Norifumi Iseda, Shinji Itoh, Yuichi Yamada, Yoshinao Oda, Mototsugu Shimokawa, Chie Kikutake, Mikita Suyama, Motoko Unoki, Hiroyuki Sasaki, Masaki Mori

Annals of Surgery   2021.6

The Significant Prognostic Factors in Prolonged Intensive/High Care Unit Stay After Living Donor Liver Transplantation. Invited Reviewed International journal

Shohei Yoshiya, Noboru Harada, Takahiro Tomiyama, Kazuki Takeishi, Takeo Toshima, Tomohiro Iguchi, Shinji Itoh, Mizuki Ninomiya, Tomoharu Yoshizumi, Masaki Mori

Transplantation proceedings   53 ( 5 )   1630 - 1638   2021.6

Prognostic Impact of Vessels that Encapsulate Tumor Cluster (VETC) in Patients who Underwent Liver Transplantation for Hepatocellular Carcinoma. Invited Reviewed International journal

Junji Kawasaki, Takeo Toshima, Tomoharu Yoshizumi, Shinji Itoh, Yohei Mano, Huanlin Wang, Norifumi Iseda, Noboru Harada, Yoshinao Oda, Masaki Mori

Annals of surgical oncology   2021.6

Feasibility of hepatic resection for liver metastasis of head-and-neck carcinoma or esophageal carcinoma: a multi-center experience. Invited Reviewed International journal

Takeshi Kurihara, Shinji Itoh, Yasue Kimura, Eiji Oki, Tomoharu Yoshizumi, Mioko Matuo, Ryuji Yasumatsu, Keishi Sugimachi, Masaru Morita, Tetsuya Kusumoto, Kengo Fukuzawa, Naoya Yoshida, Hideo Baba, Masaki Mori

Surgery today   2021.5

Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma Reviewed International journal

Inokuchi, Shoichi; Itoh, Shinji; Yoshizumi, Tomoharu; Morinaga, Akinari; Toshima, Takeo; Takeishi, Kazuki; Nagao, Yoshihiro; Harada, Noboru; Ikegami, Toru; Shimokawa, Mototsugu; Mori, Masaki

LANGENBECKS ARCHIVES OF SURGERY   406 ( 3 )   773 - 779   2021.5

Which is better to use "body weight" or "standard liver weight", for predicting small-for-size graft syndrome after living donor liver transplantation? Invited Reviewed International journal

Takeo Toshima, Tomoharu Yoshizumi, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Yoshihiro Nagao, Shinji Itoh, Noboru Harada, Masaki Mori

Annals of gastroenterological surgery   5 ( 3 )   363 - 372   2021.5

Myostatin as a fibroblast-activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma. Invited Reviewed International journal

Sachiyo Yoshio, Tomonari Shimagaki, Ryuki Hashida, Takumi Kawaguchi, Yuriko Tsutsui, Yuzuru Sakamoto, Yuichi Yoshida, Hironari Kawai, Shiori Yoshikawa, Taiji Yamazoe, Taizo Mori, Yosuke Osawa, Shinji Itoh, Moto Fukai, Tomoharu Yoshizumi, Akinobu Taketomi, Masaki Mori, Tatsuya Kanto

Hepatology research : the official journal of the Japan Society of Hepatology   2021.5

A no-ligation technique to prevent intraoperative hepatic artery dissection in living-donor liver transplantation Invited Reviewed International journal

Itoh, Shinji; Yoshizumi, Tomoharu; Harada, Noboru; Toshima, Takeo; Nagao, Yoshihiro; Kurihara, Takeshi; Wang, Huanlin; Shimagaki, Tomonari; Ikegami, Toru; Mori, Masaki

SURGERY TODAY   2021.4

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma Reviewed International journal

Iseda, Norifumi; Itoh, Shinji; Yoshizumi, Tomoharu; Yugawa, Kyohei; Morinaga, Akinari; Tomiyama, Takahiro; Toshima, Takeo; Kohashi, Kenichi; Oda, Yoshinao; Mori, Masaki

HEPATOLOGY COMMUNICATIONS   5 ( 4 )   675 - 688   2021.4

Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes Reviewed International journal

Yugawa, Kyohei; Itoh, Shinji; Yoshizumi, Tomoharu; Iseda, Norifumi; Tomiyama, Takahiro; Toshima, Takeo; Harada, Noboru; Kohashi, Kenichi; Oda, Yoshinao; Mori, Masaki

MODERN PATHOLOGY   34 ( 4 )   798 - 807   2021.4

Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy Reviewed International journal

Inokuchi, Shoichi; Yoshizumi, Tomoharu; Toshima, Takeo; Itoh, Shinji; Yugawa, Kyohei; Harada, Noboru; Mori, Hiroyuki; Fukuhara, Takasuke; Matsuura, Yoshiharu; Mori, Masaki

CANCER MEDICINE   10 ( 5 )   1501 - 1514   2021.3

Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status Reviewed International journal

Yugawa, Kyohei; Itoh, Shinji; Iseda, Norifumi; Kurihara, Takeshi; Kitamura, Yoshiyuki; Toshima, Takeo; Harada, Noboru; Kohashi, Kenichi; Baba, Shingo; Ishigami, Kousei; Oda, Yoshinao; Yoshizumi, Tomoharu; Mori, Masaki

SCIENTIFIC REPORTS   11 ( 1 )   2021.3

CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma Reviewed International journal

Yugawa, Kyohei; Itoh, Shinji; Yoshizumi, Tomoharu; Iseda, Norifumi; Tomiyama, Takahiro; Morinaga, Akinari; Toshima, Takeo; Harada, Noboru; Kohashi, Kenichi; Oda, Yoshinao; Mori, Masaki

HEPATOLOGY COMMUNICATIONS   5 ( 2 )   334 - 348   2021.2

Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p Reviewed International journal

Yugawa, Kyohei; Yoshizumi, Tomoharu; Mano, Yohei; Itoh, Shinji; Harada, Noboru; Ikegami, Toru; Kohashi, Kenichi; Oda, Yoshinao; Mori, Masaki

EJSO   47 ( 2 )   384 - 393   2021.2

Simultaneous splenectomy improves outcomes after adult living donor liver transplantation Reviewed International journal

Yoshizumi, Tomoharu; Itoh, Shinji; Shimokawa, Mototsugu; Inokuchi, Shoichi; Harada, Noboru; Takeishi, Kazuki; Mano, Yohei; Yoshiya, Shohei; Kurihara, Takeshi; Nagao, Yoshihiro; Ikegami, Toru; Soejima, Yuji; Mori, Masaki

JOURNAL OF HEPATOLOGY   74 ( 2 )   2021.2

Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma Invited Reviewed International journal

Suzuki, Hideo; Kohjima, Motoyuki; Tanaka, Masatake; Goya, Takeshi; Itoh, Shinji; Yoshizumi, Tomoharu; Mori, Masaki; Tsuda, Mariko; Takahashi, Motoi; Kurokawa, Miho; Imoto, Koji; Tashiro, Shigeki; Kuwano, Akifumi; Kato, Masaki; Okada, Seiji; Nakamuta, Makoto; Ogawa, Yoshihiro

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   2021   2021.2

Immune microenvironment in primary and metastatic liver cancers Invited Reviewed International journal

Itoh, Shinji; Yugawa, Kyohei; Yoshizumi, Tomoharu; Oda, Yoshinao; Mori, Masaki

HEPATOLOGY RESEARCH   51 ( 1 )   3 - 4   2021.1

Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma. Reviewed International journal

Kojiro Hata, Kimitaka Suetsugu, Nobuaki Egashira, Yoko Makihara, Shinji Itoh, Tomoharu Yoshizumi, Masatake Tanaka, Motoyuki Kohjima, Hiroyuki Watanabe, Satohiro Masuda, Ichiro Ieiri

Cancer chemotherapy and pharmacology   86 ( 6 )   803 - 813   2020.12

Which is better to use "body weight" or "standard liver weight", for predicting small-for-size graft syndrome after living donor liver transplantation? Reviewed International journal

Toshima, Takeo; Yoshizumi, Tomoharu; Shimagaki, Tomonari; Wang, Huanlin; Kurihara, Takeshi; Nagao, Yoshihiro; Itoh, Shinji; Harada, Noboru; Mori, Masaki

ANNALS OF GASTROENTEROLOGICAL SURGERY   2020.12

Mitochondrial expression of the DNA repair enzyme OGG1 improves the prognosis of pancreatic ductal adenocarcinoma Reviewed International journal

Inokuchi, Shoichi; Itoh, Shinji; Yoshizumi, Tomoharu; Yugawa, Kyohei; Yoshiya, Shohei; Toshima, Takeo; Takeishi, Kazuki; Iguchi, Tomohiro; Sanefuji, Kensaku; Harada, Noboru; Sugimachi, Keishi; Ikegami, Toru; Kohashi, Kenichi; Taguchi, Kenichi; Yonemasu, Hirotoshi; Fukuzawa, Kengo; Oda, Yoshinao; Mori, Masaki

PANCREATOLOGY   20 ( 6 )   1175 - 1182   2020.9

Use of Mycophenolate Mofetil Suspension as Part of Induction Therapy After Living-Donor Liver Transplant Reviewed International journal

Harada, Noboru; Yoshizumi, Tomoharu; Yoshiya, Shohei; Takeishi, Kazuki; Toshima, Takeo; Itoh, Shinji; Ikegami, Toru; Fukuda, Mio; Masuda, Satohiro; Mori, Masaki

EXPERIMENTAL AND CLINICAL TRANSPLANTATION   18 ( 4 )   485 - 490   2020.8

Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinoma Reviewed

Masafumi Ohira, Tomoharu Yoshizumi, Kyohei Yugawa, Yukiko Kosai-Fujimoto, Shoichi Inokuchi, Takashi Motomura, Yohei Mano, Takeo Toshima, Shinji Itoh, Noboru Harada, Toru Ikegami, Yuji Soejima, Akinobu Taketomi, Masaki Mori

Surgery today   50 ( 4 )   379 - 388   2020.4

Is sarcopenic obesity superior to sarcopenia as a predicting indicator in patients with hepatocellular carcinoma following hepatic resection? Reviewed International journal

Itoh, Shinji; Yoshizumi, Tomoharu; Mori, Masaki

HEPATOBILIARY SURGERY AND NUTRITION   9 ( 2 )   202 - 204   2020.4

Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation Reviewed

Takeo Toshima, Tomoharu Yoshizumi, Shoichi Inokuchi, Yukiko Kosai-Fujimoto, Takeshi Kurihara, Shohei Yoshiya, Yohei Mano, Kazuki Takeishi, Shinji Itoh, Noboru Harada, Toru Ikegami, Yuji Soejima, Mototsugu Shimokawa, Yoshihiko Maehara, Masaki Mori

HPB   22 ( 4 )   511 - 520   2020.4

Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma Reviewed

Masahiro Shimokawa, Tomoharu Yoshizumi, Shinji Itoh, Norifumi Iseda, Kazuhito Sakata, Kyohei Yugawa, Takeo Toshima, Noboru Harada, Toru Ikegami, Masaki Mori

Cancer Science   111 ( 4 )   1228 - 1240   2020.4

Living-Donor Liver Transplantation for Patients With Extrahepatic Malignancy A Series of 14 Patients in a Single Institution Reviewed

Yukiko Kosai-Fujimoto, Tomoharu Yoshizumi, Takahiro Tomiyama, Akinari Morinaga, Norifumi Iseda, Shoichi Inokuchi, Kyohei Yugawa, Shohei Yoshiya, Takeo Toshima, Kazuki Takeishi, Shinji Itoh, Noboru Harada, Toru Ikegami, Masaki Mori

Transplantation Proceedings   52 ( 3 )   889 - 893   2020.4

Prognostic impact of 8-hydroxy-deoxyguanosine and its repair enzyme 8-hydroxy-deoxyguanosine DNA glycosylase in hepatocellular carcinoma Reviewed

Kyohei Yugawa, Shinji Itoh, Tomoharu Yoshizumi, Shohei Yoshiya, Kazuki Takeishi, Takeo Toshima, Noboru Harada, Toru Ikegami, Kenichi Kohashi, Yoshinao Oda, Masaki Mori

Pathology International   2020.1

Prognostic Impact of Osteopenia in Patients Who Underwent Living Donor Liver Transplantation for Hepatocellular Carcinoma Reviewed

Takeo Toshima, Tomoharu Yoshizumi, Yukiko Kosai-Fujimoto, Shoichi Inokuchi, Shohei Yoshiya, Kazuki Takeishi, Shinji Itoh, Noboru Harada, Toru Ikegami, Yuji Soejima, Masaki Mori

World journal of surgery   44 ( 1 )   258 - 267   2020.1

Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria Reviewed

Yusuke Yonemura, Tomoharu Yoshizumi, Shoichi Inokuchi, Yukiko Kosai-Fujimoto, Noboru Harada, Shinji Itoh, Takeo Toshima, Kazuki Takeishi, Shohei Yoshiya, Masaki Mori

Annals of Gastroenterological Surgery   2020.1

Impact of middle hepatic artery reconstruction after living donor liver transplantation using the left lobe Reviewed

Noboru Harada, Tomoharu Yoshizumi, Hideaki Uchiyama, Toru Ikegami, Shinji Itoh, Kazuki Takeishi, Takeo Toshima, Yoshihiro Nagao, Shohei Yoshiya, Masaki Mori

Clinical Transplantation   2020.1

Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI Reviewed

Kazuki Takeishi, Tomoharu Yoshizumi, Shinji Itoh, Kyohei Yugawa, Shohei Yoshiya, Takeo Toshima, Noboru Harada, Toru Ikegami, Akihiro Nishie, Masaki Mori

Annals of Surgical Oncology   2020.1

Prognostic nutritional index is superior as a predictor of prognosis among various inflammation-based prognostic scores in patients with hepatocellular carcinoma after curative resection Reviewed

Daisuke Imai, Takashi Maeda, Mototsugu Shimokawa, Huanlin Wang, Shohei Yoshiya, Kazuki Takeishi, Shinji Itoh, Noboru Harada, Toru Ikegami, Tomoharu Yoshizumi, Masaki Mori

Hepatology Research   50 ( 1 )   101 - 109   2020.1

Extensive Thrombectomy as a Legitimate Strategy in Living Donor Liver Transplantation With Advanced Portal Vein Thrombosis Reviewed

Toru Ikegami, Tomoharu Yoshizumi, Yuriko Tsutsui, Noboru Harada, Shinji Itoh, Shohei Yoshiya, Daisuke Imai, Hideaki Uchiyama, Masaki Mori

Liver Transplantation   25 ( 12 )   1768 - 1777   2019.12

The evolution of surgical treatment for gastrointestinal cancers Reviewed

Yoshihiko Maehara, Yuji Soejima, Tomoharu Yoshizumi, Naoyuki Kawahara, Eiji Oki, Hiroshi Saeki, Tomohiko Akahoshi, Toru Ikegami, Yo ichi Yamashita, Tadashi Furuyama, Keishi Sugimachi, Noboru Harada, Tetsuzo Tagawa, Norifumi Harimoto, Shinji Itoh, Hideto Sonoda, Koji Ando, Yuichiro Nakashima, Yoshihiro Nagao, Nami Yamashita, Yuta Kasagi, Takafumi Yukaya, Takeshi Kurihara, Ryosuke Tsutsumi, Shinkichi Takamori, Shun Sasaki, Tetsuo Ikeda, Yoshikazu Yonemitsu, Takasuke Fukuhara, Hiroyuki Kitao, Makoto Iimori, Yuki Kataoka, Takeshi Wakasa, Masami Suzuki, Koji Teraishi, Yasuto Yoshida, Masaki Mori

International Journal of Clinical Oncology   24 ( 11 )   1333 - 1349   2019.11

Elevation of Mac-2 binding protein glycosylation isomer after hepatectomy is associated with post-hepatectomy liver failure, total Pringle time, and renal dysfunction Reviewed

Daisuke Imai, Takashi Maeda, Huanlin Wang, Kensaku Sanefuji, Hiroto Kayashima, Shohei Yoshiya, Kazuki Takeishi, Shinji Itoh, Noboru Harada, Toru Ikegami, Tomoharu Yoshizumi, Masaki Mori

Annals of Gastroenterological Surgery   3 ( 5 )   515 - 522   2019.9

IFN-γ Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer Reviewed

240   115 - 123   2019.8

The role of DNA repair glycosylase OGG1 in intrahepatic cholangiocarcinoma Reviewed

Kazuhito Sakata, Tomoharu Yoshizumi, Takuma Izumi, Masahiro Shimokawa, Shinji Itoh, Toru Ikegami, Noboru Harada, Takeo Toshima, Yohei Mano, Masaki Mori

Anticancer research   39 ( 6 )   3241 - 3248   2019.1

Efficacy of Neoadjuvant Chemotherapy in Distal Pancreatectomy with En Bloc Celiac Axis Resection (DP-CAR) for Locally Advanced Pancreatic Cancer Reviewed

Shohei Yoshiya, Kengo Fukuzawa, Shoichi Inokuchi, Yukiko Kosai-Fujimoto, Kensaku Sanefuji, Kentaro Iwaki, Akira Motohiro, Shinji Itoh, Noboru Harada, Toru Ikegami, Tomoharu Yoshizumi, Masaki Mori

Journal of Gastrointestinal Surgery   2019.1

Ectopic localization of autophagosome in fatty liver is a key factor for liver regeneration Reviewed

Yoshihiro Matsumoto, Tomoharu Yoshizumi, Takeo Toshima, Kazuki Takeishi, Takasuke Fukuhara, Shinji Itoh, Toru Ikegami, Yuji Soejima, Masaki Mori

Organogenesis   15 ( 1 )   24 - 34   2019.1

Skeletal muscle mass predicts the prognosis of patients with intrahepatic cholangiocarcinoma Reviewed

Kyohei Yugawa, shinji itoh, Takeshi Kurihara, Shohei Yoshiya, Yohei Mano, kazuki takeishi, Noboru Harada, Toru Ikegami, Yuji Soejima, Masaki Mori, Tomoharu Yoshizumi

American Journal of Surgery   2019.1

Impact of hepatic artery size mismatch between donor and recipient on outcomes after living-donor liver transplantation using the right lobe Reviewed

Noboru Harada, Tomoharu Yoshizumi, Hideaki Uchiyama, Yuji Soejima, Toru Ikegami, shinji itoh

Clinical Transplantation   33 ( 1 )   2019.1

Feasibility of All-in-One Venoplasty With a Venous Cuff Using an Opened Round Ligament for the Right Lobe Graft in Living Donor Liver Transplantation Reviewed

Takeo Toshima, Tomoharu Yoshizumi, Masahiro Shimokawa, Toru Ikegami, Noboru Harada, shinji itoh, Yohei Mano, Takashi Motomura, Yuji Soejima, Yoshihiko Maehara

Liver Transplantation   25 ( 1 )   171 - 175   2019.1

Functional Analysis of Human Hepatocytes Isolated From Chimeric Mouse Liver Reviewed

N. Harimoto, H. Nakagawara, K. Shirabe, Tomoharu Yoshizumi, shinji itoh, Toru Ikegami, Yuji Soejima, Y. Maehara, Y. Ishida, C. Tateno, Y. Tanaka

Transplantation Proceedings   50 ( 10 )   3858 - 3862   2018.12

Impact of osteopenia in liver cirrhosis Special reference to standard bone mineral density with age Reviewed

Takeo Toshima, Tomoharu Yoshizumi, Toru Ikegami, Noboru Harada, shinji itoh, Yohei Mano, Takashi Motomura, Yuji Soejima, Yoshihiko Maehara

Anticancer research   38 ( 11 )   6465 - 6471   2018.11

Lymphocyte-to-Monocyte Ratio Is a Predictor of Survival After Liver Transplantation for Hepatocellular Carcinoma Reviewed

Yohei Mano, Tomoharu Yoshizumi, Kyohei Yugawa, Masafumi Ohira, Takashi Motomura, Takeo Toshima, shinji itoh, Noboru Harada, Toru Ikegami, Yuji Soejima, Yoshihiko Maehara

Liver Transplantation   24 ( 11 )   1603 - 1611   2018.11

Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma A Multi-institutional Study Reviewed

Norifumi Harimoto, Tomoharu Yoshizumi, Shoichi Inokuchi, shinji itoh, Eisuke Adachi, Yasuharu Ikeda, Hideaki Uchiyama, Tohru Utsunomiya, Kiyoshi Kajiyama, Koichi Kimura, Fumiaki Kishihara, Keishi Sugimachi, Eiji Tsujita, Mizuki Ninomiya, Kengo Fukuzawa, Takashi Maeda, Ken Shirabe, Yoshihiko Maehara

Annals of Surgical Oncology   25 ( 11 )   3316 - 3323   2018.10

Serum asunaprevir and daclatasvir concentrations and outcomes in patients with recurrent hepatitis C who have undergone living donor liver transplantation Reviewed

Noboru Harada, Tomoharu Yoshizumi, Toru Ikegami, shinji itoh, Norihiro Furusho, Masaki Kato, Shinji Shimoda, Takasuke Fukuhara, Yuji Soejima, Yoshihiko Maehara

Anticancer research   38 ( 9 )   5513 - 5520   2018.9

Long-term Outcomes and Risk Factors after Adult Living Donor Liver Transplantation Reviewed

Daisuke Imai, Tomoharu Yoshizumi, Kazuhito Sakata, Toru Ikegami, shinji itoh, Noboru Harada, Takashi Motomura, Takeo Toshima, Yohei Mano, Yuji Soejima, Yoshihiko Maehara

Transplantation   102 ( 9 )   e382 - e391   2018.9

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma Reviewed

Hirohisa Okabe, Tomoharu Yoshizumi, Yo Ichi Yamashita, Katsunori Imai, Hiromitsu Hayashi, Shigeki Nakagawa, shinji itoh, Norifumi Harimoto, Toru Ikegami, Hideaki Uchiyama, Toru Beppu, Shinichi Aishima, Ken Shirabe, Hideo Baba, Yoshihiko Maehara

PloS one   13 ( 9 )   2018.9

Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy Reviewed

Kazuki Takeishi, Hirofumi Kawanaka, shinji itoh, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Ken Shirabe, Yoshihiko Maehara

World Journal of Surgery   42 ( 4 )   1120 - 1128   2018.4

Potential effect of recombinant thrombomodulin on ischemia–reperfusion liver injury in rats Reviewed

48 ( 5 )   391 - 396   2018.4

Associations between antibody to hepatitis B core antigen positivity and outcomes in hepatocellular carcinoma patients undergoing hepatic resection Reviewed

shinji itoh, Tomoharu Yoshizumi, Takahiro Tomino, Akihisa Nagatsu, Takashi Motomura, Noboru Harada, Norifumi Harimoto, Toru Ikegami, Yuji Soejima, Yoshihiko Maehara

Hepatology Research   48 ( 3 )   E155 - E161   2018.2

Customization of laparoscopic gastric devascularization and splenectomy for gastric varices based on CT vascular anatomy Reviewed

Hirofumi Kawanaka, Tomohiko Akahoshi, Yoshihiro Nagao, Nao Kinjo, Daisuke Yoshida, Yoshihiro Matsumoto, Norifumi Harimoto, shinji itoh, Tomoharu Yoshizumi, Yoshihiko Maehara

Surgical Endoscopy   32 ( 1 )   114 - 126   2018.1

Slow Gait Speed Is a Risk Factor for Complications After Hepatic Resection Reviewed

shinji itoh, Tomoharu Yoshizumi, Kazuhisa Sakata, Takashi Motomura, Yohei Mano, Takeo Toshima, Norifumi Harimoto, Noboru Harada, Toru Ikegami, Yuji Soejima, Ryuichi Kusaba, Takahide Kamishima, Akihiro Nishie, Yoshihiko Maehara

Journal of Gastrointestinal Surgery   2018.1

Surgery for Hepatocellular Carcinoma in Patients with Child–Pugh B Cirrhosis Hepatic Resection Versus Living Donor Liver Transplantation Reviewed

1 - 11   2018.1

Hepatobiliary and Pancreatic Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation Reviewed

Norifumi Harimoto, K. Yugawa, Toru Ikegami, M. Ohira, Yohei Mano, T. Motomura, Takeo Toshima, shinji itoh, N. Harada, Yuji Soejima, Tomoharu Yoshizumi, Yoshihiko Maehara, Yoshinao Oda

Journal of Gastroenterology and Hepatology (Australia)   33 ( 1 )   2018.1

Living donor liver transplantation for hepatocellular carcinoma results of prospective patient selection by Kyushu University Criteria in 7 years Reviewed

Hideaki Uchiyama, shinji itoh, Tomoharu Yoshizumi, Toru Ikegami, Norifumi Harimoto, Yuji Soejima, Noboru Harada, Kazutoyo Morita, Takeo Toshima, Takashi Motomura, Yoshihiko Maehara

HPB   19 ( 12 )   1082 - 1090   2017.12

Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed Reviewed

Norifumi Harimoto, Tomoharu Yoshizumi, T. Izumi, T. Motomura, Noboru Harada, shinji itoh, Toru Ikegami, H. Uchiyama, Yuji Soejima, Akihiro Nishie, T. Kamishima, R. Kusaba, K. Shirabe, Yoshihiko Maehara

Transplantation Proceedings   49 ( 9 )   2144 - 2152   2017.11

Prognostic significance of combined albumin–bilirubin and tumor–node–metastasis staging system in patients who underwent hepatic resection for hepatocellular carcinoma Reviewed

47 ( 12 )   1289 - 1298   2017.11

Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma Reviewed

Norifumi Harimoto, Tomoharu Yoshizumi, Kazuhito Sakata, Akihisa Nagatsu, Takashi Motomura, shinji itoh, Noboru Harada, Toru Ikegami, Hideaki Uchiyama, Yuji Soejima, Yoshihiko Maehara

World Journal of Surgery   41 ( 11 )   2805 - 2812   2017.11

p62 Promotes Amino Acid Sensitivity of mTOR Pathway and Hepatic Differentiation in Adult Liver Stem/Progenitor Cells Reviewed

Masakazu Sugiyama, Tomoharu Yoshizumi, Yoshihiro Yoshida, Yuki Bekki, Yoshihiro Matsumoto, Shohei Yoshiya, Takeo Toshima, Toru Ikegami, shinji itoh, Norifumi Harimoto, Shinji Okano, Yuji Soejima, Ken Shirabe, Yoshihiko Maehara

Journal of Cellular Physiology   232 ( 8 )   2112 - 2124   2017.8

The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer Reviewed

Daisuke Imai, Tomoharu Yoshizumi, Shinji Okano, Hideaki Uchiyama, Toru Ikegami, Norifumi Harimoto, shinji itoh, Yuji Soejima, Shinichi Aishima, Yoshinao Oda, Yoshihiko Maehara

Cancer Medicine   6 ( 7 )   1614 - 1626   2017.7

Impact and prediction of lymph node involvement in patients with intrahepatic cholangiocarcinoma after curative resection Reviewed

Noboru Harada, Tomoharu Yoshizumi, Yo Ichi Yamashita, Yuji Soejima, Toru Ikegami, Norifumi Harimoto, shinji itoh, Yoshihiko Maehara

Anticancer Research   37 ( 7 )   3763 - 3769   2017.7

Hepatic stellate cells secreting WFA⁺-M2BP Its role in biological interactions with Kupffer cells Reviewed

Yuki Bekki, Tomoharu Yoshizumi, Shinji Shimoda, shinji itoh, Norifumi Harimoto, Toru Ikegami, Atsushi Kuno, Hisashi Narimatsu, Ken Shirabe, Yoshihiko Maehara

Journal of Gastroenterology and Hepatology (Australia)   32 ( 7 )   1387 - 1393   2017.7

Shape and Enhancement Characteristics of Pancreatic Neuroendocrine Tumor on Preoperative Contrast-enhanced Computed Tomography May be Prognostic Indicators Reviewed

Hirohisa Okabe, Daisuke Hashimoto, Akira Chikamoto, Morikatsu Yoshida, Katsunobu Taki, Kota Arima, Katsunori Imai, Yoshitaka Tamura, Osamu Ikeda, Takatoshi Ishiko, Hideaki Uchiyama, Toru Ikegami, Norifumi Harimoto, shinji itoh, Yo ichi Yamashita, Tomoharu Yoshizumi, Toru Beppu, Yasuyuki Yamashita, Hideo Baba, Yoshihiko Maehara

Annals of Surgical Oncology   24 ( 5 )   1399 - 1405   2017.5

Surgical treatment and outcome of patients with de novo lung cancer after liver transplantation Reviewed

Fumihiro Shoji, Gouji Toyokawa, Noboru Harada, shinji itoh, Norifumi Harimoto, Toru Ikegami, Tatsuro Okamoto, Yuji Soejima, Tomoharu Yoshizumi, Yoshihiko Maehara

Anticancer Research   37 ( 5 )   2619 - 2623   2017.5

Pleural Effusion After Hepatectomy for Hepatocellular Carcinoma Risk Factor Analyses and Its Impact on Oncological Outcomes Reviewed

Hideaki Uchiyama, Norifumi Harimoto, shinji itoh, Tomoharu Yoshizumi, Toru Ikegami, Yoshihiko Maehara

World Journal of Surgery   41 ( 4 )   1089 - 1099   2017.4

Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma Reviewed

shinji itoh, Tomoharu Yoshizumi, Ken Shirabe, Koichi Kimura, Hirohisa Okabe, Norifumi Harimoto, Toru Ikegami, Hideaki Uchiyama, Akihiro Nishie, Yoshihiko Maehara

Hepatology Research   47 ( 5 )   398 - 404   2017.4

Preoperative pancreatic stiffness by real-time tissue elastography to predict pancreatic fistula after pancreaticoduodenectomy Reviewed

Noboru Harada, Tomoharu Yoshizumi, Takashi Maeda, Hiroto Kayashima, Toru Ikegami, Norifumi Harimoto, shinji itoh, Yoshihiko Maehara

Anticancer Research   37 ( 4 )   1909 - 1915   2017.4

Post-hepatectomy refractory ascites in cirrhotic patients with hepatocellular carcinoma Risk factor analysis to overcome this problematic complication Reviewed

shinji itoh, Hideaki Uchiyama, Yasuharu Ikeda, Kazutoyo Morita, Noboru Harada, Keishi Sugimachi, Hirofumi Kawanaka, Daisuke Korenaga, Tomoharu Yoshizumi, Kenji Takenaka, Yoshihiko Maehara

Anticancer Research   37 ( 3 )   1381 - 1385   2017.3

Eversion technique to prevent biliary stricture after living donor liver transplantation in the universal minimal hilar dissection era Reviewed

Toru Ikegami, Tomonari Shimagaki, Junji Kawasaki, Tomoharu Yoshizumi, Hideaki Uchiyama, Noboru Harada, Norifumi Harimoto, shinji itoh, Yuji Soejima, Yoshihiko Maehara

Transplantation   101 ( 1 )   e20 - e25   2017.1

Role of autophagy in liver regeneration

Takeo Toshima, Ken Shirabe, Yoshihiro Matsumoto, Shinji Itoh, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Yoshihiko Maehara

Autophagy Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging Volume 12   451 - 461   2017.1

Use of internal jugular vein grafts in reconstructing multiple venous orifices of right hepatic grafts without the middle hepatic vein trunk Reviewed

Hideaki Uchiyama, Tomoharu Yoshizumi, Toru Ikegami, Norifumi Harimoto, shinji itoh, Hirohisa Okabe, Yuji Soejima, Yoshihiko Maehara

Liver Transplantation   23 ( 1 )   110 - 116   2017.1

Surgical resection of giant pheochromocytomas arising behind the retrohepatic inferior vena cava Reviewed

Yuji Soejima, Tomoharu Yoshizumi, Toru Ikegami, Norifumi Harimoto, shinji itoh, Noboru Harada, Takashi Motomura, Akihisa Nagatsu, Tetsuo Ikeda, Yoshihiko Maehara

Anticancer Research   37 ( 1 )   277 - 280   2017.1

Surgical resection for lymph node metastasis after liver transplantation for hepatocellular carcinoma Reviewed

Toru Ikegami, Tomoharu Yoshizumi, Jyunji Kawasaki, Akihisa Nagatsu, Hideaki Uchiyama, Noboru Harada, Norifumi Harimoto, shinji itoh, Takashi Motomura, Yuji Soejima, Yoshihiko Maehara

Anticancer Research   37 ( 2 )   891 - 896   2017.1

Left lobe living donor liver transplantation in adults What is the safety limit? Reviewed

Toru Ikegami, Tomoharu Yoshizumi, Kazuhito Sakata, Hideaki Uchiyama, Norifumi Harimoto, Noboru Harada, shinji itoh, Akihisa Nagatsu, Yuji Soejima, Yoshihiko Maehara

Liver Transplantation   22 ( 12 )   1666 - 1675   2016.12

The learning curves in living donor hemiliver graft procurement using small upper midline incision Reviewed

Toru Ikegami, Norifumi Harimoto, Masahiro Shimokawa, Tomoharu Yoshizumi, Hideaki Uchiyama, shinji itoh, Norihisa Okabe, Kazuhito Sakata, Akihisa Nagatsu, Yuji Soejima, Yoshihiko Maehara

Clinical Transplantation   30 ( 12 )   1532 - 1537   2016.12

Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma Reviewed

46 ( 12 )   1247 - 1255   2016.11

Inflammation-based prognostic score in patients with living donor liver transplantation for hepatocellular carcinoma Reviewed

Norifumi Harimoto, Tomoharu Yoshizumi, Tomonari Shimagaki, Akihisa Nagatsu, Takashi Motomura, Noboru Harada, Hirohisa Okabe, shinji itoh, Toru Ikegami, Hideaki Uchiyama, Yuji Soejima, Yoshihiko Maehara

Anticancer Research   36 ( 10 )   5537 - 5542   2016.10

The use of left grafts with a replaced or accessory left hepatic artery in adult-to-adult living donor liver transplantation analyses of donor and recipient outcomes Reviewed

Hideaki Uchiyama, Tomoharu Yoshizumi, Toru Ikegami, Norifumi Harimoto, shinji itoh, Hirohisa Okabe, Koichi Kimura, Yoshihiko Maehara

Clinical Transplantation   30 ( 9 )   1021 - 1027   2016.9

Validity of hepatic or pancreatic resection for elderly patients aged 85 years or older at a single community hospital in Japan Reviewed

shinji itoh, Shunji Kohnoe, Ken Shirabe, Daisuke Yoshida, Hirofumi Kawanaka, Tomoharu Yoshizumi, Toru Ikegami, Yo Ichi Yamashita, Takeshi Kurihara, Yoshihiko Maehara

Anticancer Research   36 ( 8 )   4289 - 4292   2016.8

Graft selection strategy in adult-to-adult living donor liver transplantation When both hemiliver grafts meet volumetric criteria Reviewed

Takeshi Kurihara, Tomoharu Yoshizumi, Yoshihiro Yoshida, Toru Ikegami, shinji itoh, Norifumi Harimoto, Mizuki Ninomiya, Hideaki Uchiyama, Hirohisa Okabe, Koichi Kimura, Hirofumi Kawanaka, Ken Shirabe, Yoshihiko Maehara

Liver Transplantation   22 ( 7 )   914 - 922   2016.7

Inquiries About Biomarkers of Acute Liver Failure in Patients Who Underwent Living Donor Liver Transplantation Using a Protein Chip Array Reviewed

Yo ichi Yamashita, Tomoharu Yoshizumi, Toru Ikegami, Hideaki Uchiyama, Eiji Tsujita, shinji itoh, Norifumi Harimoto, Yuji Soejima, Akinobu Taketomi, Hideo Baba, Yoshihiko Maehara

Fukuoka Acta Medica   107 ( 7 )   131 - 135   2016.7

Effect of sarcopenic obesity on outcomes of living-donor liver transplantation for hepatocellular carcinoma Reviewed

shinji itoh, Tomoharu Yoshizumi, Koichi Kimura, Hirohisa Okabe, Norifumi Harimoto, Toru Ikegami, Hideaki Uchiyama, Ken Shirabe, Akihiro Nishie, Yoshihiko Maehara

Anticancer Research   36 ( 6 )   3029 - 3034   2016.6

Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation Reviewed

Kazutoyo Morita, Ken Shirabe, Akinobu Taketomi, Yuji Soejima, Tomoharu Yoshizumi, Hideaki Uchiyama, Toru Ikegami, Yo Ichi Yamashita, Keishi Sugimachi, Norifumi Harimoto, shinji itoh, Tetsuo Ikeda, Yoshihiko Maehara

Liver Transplantation   22 ( 5 )   665 - 676   2016.5

CURRENT STATUS OF HEPATOBILIARY PANCREATIC SURGERY FOR ELDERLY PATIENTS Reviewed

Tomoharu Yoshizumi, Norifumi Harimoto, shinji itoh, Toru Ikegami, Hideaki Uchiyama, Tetsuo Ikeda, Yoshihiko Maehara

Nihon Geka Gakkai zasshi   117 ( 3 )   174 - 181   2016.5

Diverse basis of β-catenin activation in human hepatocellular carcinoma Implications in biology and prognosis Reviewed

11 ( 4 )   2016.4

Skeletal muscle mass assessed by computed tomography correlates to muscle strength and physical performance at a liver-related hospital experience Reviewed

shinji itoh, Ken Shirabe, Tomoharu Yoshizumi, Kazuki Takeishi, Norifumi Harimoto, Toru Ikegami, Hirofumi Kawanaka, Akihiro Nishie, Takahide Kamishima, Yoshihiko Maehara

Hepatology Research   46 ( 4 )   292 - 297   2016.4

Living donor liver transplantation for intrahepatic arteriovenous fistula with hepatic artery reconstruction using the right gastroepiploic artery Reviewed

Hideaki Uchiyama, Ken Shirabe, Tomoharu Yoshizumi, Toru Ikegami, Norifumi Harimoto, shinji itoh, Koichi Kimura, Hirohisa Okabe, Yoshihiko Maehara

Liver Transplantation   22 ( 4 )   552 - 556   2016.4

Telaprevir versus simeprevir for the treatment of recurrent hepatitis C after living donor liver transplantation Reviewed

Toru Ikegami, Tomoharu Yoshizumi, Yoshihro Yoshida, Takeshi Kurihara, Norifumi Harimoto, shinji itoh, Masahiro Shimokawa, Takasuke Fukuhara, Ken Shirabe, Yoshihiko Maehara

Hepatology Research   46 ( 3 )   E136 - E145   2016.3

A Cohort Study for Derivation and Validation of Early Detection of Pancreatic Fistula After Pancreaticoduodenectomy Reviewed

Kazuki Takeishi, Takashi Maeda, Yo ichi Yamashita, Eiji Tsujita, shinji itoh, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Ken Shirabe, Yoshihiko Maehara

Journal of Gastrointestinal Surgery   20 ( 2 )   385 - 391   2016.2

Predictors of Benign Status in Liver Tumors Under 3 cm in Diameter Misdiagnosed as Hepatocellular Carcinoma Reviewed

Koichi Kimura, shinji itoh, Takeshi Kurihara, Yoshihiro Yoshida, Huanlin Wang, Norifumi Harimoto, Akihiro Nishie, Ken Shirabe, Yoshinao Oda, Yoshihiko Maehara

Anticancer Research   36 ( 2 )   793 - 797   2016.2

Impact of recombinant human soluble thrombomodulin for disseminated intravascular coagulation Reviewed

shinji itoh, Ken Shirabe, Shunji Kohnoe, Noriaki Sadanaga, Kiyoshi Kajiyama, Motoyuki Yamagata, Hideaki Anai, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Yoshihiko Maehara

Anticancer Research   36 ( 5 )   2493 - 2496   2016.1

Surgical results of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma A multi-institutional retrospective study of 174 patients Reviewed

Yo Ichi Yamashita, Tomoharu Yoshizumi, Kengo Fukuzawa, Takashi Nishizaki, Eiji Tsujita, Kiyoshi Kajiyama, Yuji Soejima, Motoyuki Yamagata, Kazuharu Yamamoto, Eisuke Adachi, Keishi Sugimachi, Yasuharu Ikeda, Hideaki Uchiyama, Takashi Maeda, shinji itoh, Norifumi Harimoto, Toru Ikegami, Yoshihiko Maehara

Anticancer Research   36 ( 5 )   2407 - 2412   2016.1

Living Donor Liver Transplantation for Hepatocellular Carcinoma within Milan Criteria in the Present Era Reviewed

Tomoharu Yoshizumi, Norifumi Harimoto, shinji itoh, Hirohisa Okabe, Koichi Kimura, Hideaki Uchiyama, Toru Ikegami, Tetsuo Ikeda, Yoshihiko Maehara

Anticancer Research   36 ( 1 )   439 - 445   2016.1

Ischemia-reperfusion injury in fatty liver is mediated by activated NADPH oxidase 2 in rats Reviewed

Koichi Kimura, Ken Shirabe, Tomoharu Yoshizumi, Kazuki Takeishi, shinji itoh, Norifumi Harimoto, Toru Ikegami, Hideaki Uchiyama, Shinji Okano, Yoshihiko Maehara

Transplantation   100 ( 4 )   791 - 800   2016.1

Impact of recombinant human soluble thrombomodulin for disseminated intravascular coagulation Reviewed

shinji itoh, Ken Shirabe, Shunji Kohnoe, Noriaki Sadanaga, Kiyoshi Kajiyama, Motoyuki Yamagata, Hideaki Anai, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Yoshihiko Maehara

Anticancer Research   36 ( 5 )   2493 - 2496   2016.1

Favorable Outcomes of Hepatectomy for Ruptured Hepatocellular Carcinoma Retrospective Analysis of Primary R0-Hepatectomized Patients Reviewed

Hideaki Uchiyama, Ryosuke Minagawa, shinji itoh, Kiyoshi Kajiyama, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Ken Shirabe, Kenji Takenaka, Yoshihiko Maehara

Anticancer Research   36 ( 1 )   379 - 385   2016.1

Surgical results of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma A multi-institutional retrospective study of 174 patients Reviewed

Yo Ichi Yamashita, Tomoharu Yoshizumi, Kengo Fukuzawa, Takashi Nishizaki, Eiji Tsujita, Kiyoshi Kajiyama, Yuji Soejima, Motoyuki Yamagata, Kazuharu Yamamoto, Eisuke Adachi, Keishi Sugimachi, Yasuharu Ikeda, Hideaki Uchiyama, Takashi Maeda, shinji itoh, Norifumi Harimoto, Toru Ikegami, Yoshihiko Maehara

Anticancer Research   36 ( 5 )   2407 - 2412   2016.1

Living Donor Liver Transplantation for Hepatocellular Carcinoma within Milan Criteria in the Present Era Reviewed

Tomoharu Yoshizumi, Norifumi Harimoto, shinji itoh, Hirohisa Okabe, Koichi Kimura, Hideaki Uchiyama, Toru Ikegami, Tetsuo Ikeda, Yoshihiko Maehara

Anticancer Research   36 ( 1 )   439 - 445   2016.1

Ischemia-reperfusion injury in fatty liver is mediated by activated NADPH oxidase 2 in rats Reviewed

Koichi Kimura, Ken Shirabe, Tomoharu Yoshizumi, Kazuki Takeishi, shinji itoh, Norifumi Harimoto, Toru Ikegami, Hideaki Uchiyama, Shinji Okano, Yoshihiko Maehara

Transplantation   100 ( 4 )   791 - 800   2016.1

Clinicopathologic Features and Outcomes of Non-B, Non-C Hepatocellular Carcinoma After Hepatectomy Reviewed

Kazuki Takeishi, Takashi Maeda, Ken Shirabe, Eiji Tsujita, Yo ichi Yamashita, Norifumi Harimoto, shinji itoh, Toru Ikegami, Tomoharu Yoshizumi, Yoshihiko Maehara

Annals of Surgical Oncology   22   1116 - 1124   2015.12

Risk factors for hepatitis B virus recurrence after living donor liver transplantation A 17-year experience at a single center Reviewed

Sung Kwan Bae, Shinji Shimoda, Toru Ikegami, Tomoharu Yoshizumi, Norifumi Harimoto, shinji itoh, Yuji Soejima, Hideaki Uchiyama, Ken Shirabe, Yoshihiko Maehara

Hepatology Research   45 ( 12 )   1203 - 1210   2015.12

Profile of plasma amino acids values as a predictor of sepsis in patients following living donor liver transplantation Special reference to sarcopenia and postoperative early nutrition Reviewed

Takeo Toshima, Ken Shirabe, Takeshi Kurihara, shinji itoh, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Hirofumi Kawanaka, Tetsuo Ikeda, Yoshihiko Maehara

Hepatology Research   45 ( 12 )   1170 - 1177   2015.12

Pancreatic Transection Using Tape Sling and Ultrasonic Aspirator Dissection Technique in Pancreaticoduodenectomy and Distal Pancreatectomy Reviewed

Hideaki Uchiyama, Kazutoyo Morita, shinji itoh, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Ken Shirabe, Kenji Takenaka, Yoshihiko Maehara

Journal of the American College of Surgeons   221 ( 5 )   e91 - e95   2015.11

Predictors of the Effectiveness of Prophylactic Drains after Hepatic Resection Reviewed

Yuki Bekki, Yo Ichi Yamashita, shinji itoh, Norifumi Harimoto, Ken Shirabe, Yoshihiko Maehara

World Journal of Surgery   39 ( 10 )   2543 - 2549   2015.10

Indocyanine Green Fluorescent Imaging for Hepatic Resection of the Right Hepatic Vein Drainage Area Reviewed

Takeshi Kurihara, Yo Ichi Yamashita, Yoshihiro Yoshida, Kazuki Takeishi, shinji itoh, Norifumi Harimoto, Tomoharu Yoshizumi, Ken Shirabe, Tetsuo Ikeda, Yoshihiko Maehara

Journal of the American College of Surgeons   221 ( 3 )   e49 - e53   2015.9

The changes in treatment strategies in ABOi living donor liver transplantation for acute liver failure Reviewed

Mitsuhiro Yasuda, Toru Ikegami, Daisuke Imai, Huanlin Wang, Yuki Bekki, shinji itoh, Tomoharu Yoshizumi, Yuji Soejima, Ken Shirabe, Yoshihiko Maehara

Journal of Medical Investigation   62 ( 3 )   184 - 187   2015.9

Optimal changes in portal hemodynamics induced by splenectomy during living donor liver transplantation Reviewed

Huanlin Wang, Toru Ikegami, Noboru Harada, Tomoharu Yoshizumi, Yuji Soejima, Hideaki Uchiyama, Yo Ichi Yamashita, shinji itoh, Norifumi Harimoto, Hirofumi Kawanaka, Ken Shirabe, Yoshihiko Maehara

Surgery Today   45 ( 8 )   979 - 985   2015.8

Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy Repeat hepatectomy versus salvage living donor liver transplantation Reviewed

Yo Ichi Yamashita, Yoshihiro Yoshida, Takeshi Kurihara, shinji itoh, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Hideaki Uchiyama, Ken Shirabe, Yoshihiko Maehara

Liver Transplantation   21 ( 7 )   961 - 968   2015.7

Impact of platelets and serotonin on liver regeneration after living donor hepatectomy Reviewed

Tomoharu Yoshizumi, shinji itoh, D. Imai, Toru Ikegami, M. Ninomiya, T. Iguchi, Norifumi Harimoto, K. Takeishi, Y. Kimura, H. Uchiyama, Yuji Soejima, Tetsuo Ikeda, H. Kawanaka, K. Shirabe, Yoshihiko Maehara

Transplantation Proceedings   47 ( 3 )   683 - 685   2015.4

Triple therapy using direct-acting agents for recurrent hepatitis C after liver transplantation A single-center experience Reviewed

Toru Ikegami, Tomoharu Yoshizumi, Yuji Soejima, Norifumi Harimoto, shinji itoh, K. Takeishi, H. Uchiyama, H. Kawanaka, Y. I. Yamashita, E. Tsujita, Noboru Harada, Eiji Oki, Hiroshi Saeki, Y. Kimura, K. Shirabe, Yoshihiko Maehara

Transplantation Proceedings   47 ( 3 )   730 - 732   2015.4

Right paraduodenal hernia successfully treated with laparoscopic surgery Reviewed

Takahiro Tomino, shinji itoh, Daisuke Yoshida, Takahiro Nishida, Hirofumi Kawanaka, Tetsuo Ikeda, Shunji Kohnoe, Ken Shirabe, Yoshihiko Maehara

Asian journal of endoscopic surgery   8 ( 1 )   87 - 90   2015.2

BiClamp-Fracture Method in Pure Laparoscopic Hepatectomy Verifying its Efficacy Irrespective of Liver Stiffness Reviewed

Hideaki Uchiyama, Kazutoyo Morita, shinji itoh, Kenji Takenaka, Yoshihiko Maehara

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques   25 ( 4 )   e113 - e116   2015.1

Prognostic impact of Des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma Reviewed

47 ( 3 )   703 - 704   2015.1

Predictors of intrahepatic multiple recurrences after curative hepatectomy for hepatocellular carcinoma Reviewed

Kazuki Takeishi, Takashi Maeda, Eiji Tsujita, Yo Ichi Yamashita, Noboru Harada, shinji itoh, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Ken Shirabe, Yoshihiko Maehara

Anticancer Research   35 ( 5 )   3061 - 3066   2015.1

Outcomes after laparoscopic hepatectomy in the semi-prone position for hepatocellular carcinoma located in segment 6,7, or 8 Reviewed

Norifumi Harimoto, Tetsuo Ikeda, Kazuki Takeishi, shinji itoh, Yo Ichi Yamashita, Toru Ikegami, Tomoharu Yoshizumi, Hirofumi Kawanaka, Ken Shirabe, Yoshihiko Maehara

Anticancer Research   35 ( 7 )   4167 - 4170   2015.1

Long-term outcome of living-donor liver transplantation for combined hepatocellular-cholangiocarcinoma Reviewed

shinji itoh, Toru Ikegami, Tomoharu Yoshizumi, Huanlin Wang, Kazuki Takeishi, Norifumi Harimoto, Yo Ichi Yamashita, Hirofumi Kawanaka, Shinichi Aishima, Ken Shirabe, Yoshihiko Maehara

Anticancer Research   35 ( 4 )   2475 - 2476   2015.1

Laparoscopic Splenectomy with Technical Standardization and Selection Criteria for Standard or Hand-Assisted Approach in 390 Patients with Liver Cirrhosis and Portal Hypertension Reviewed

Hirofumi Kawanaka, Tomohiko Akahoshi, Nao Kinjo, Norifumi Harimoto, shinji itoh, Norifumi Tsutsumi, Yoshihiro Matsumoto, Tomoharu Yoshizumi, Ken Shirabe, Yoshihiko Maehara

Journal of the American College of Surgeons   221 ( 2 )   354 - 366   2015.1

Correlation between portal vein anatomy and bile duct variation in 407 living liver donors Reviewed

K. Takeishi, K. Shirabe, Y. Yoshida, Y. Tsutsui, T. Kurihara, K. Kimura, shinji itoh, Norifumi Harimoto, Y. I. Yamashita, Toru Ikegami, Tomoharu Yoshizumi, Akihiro Nishie, Yoshihiko Maehara

American Journal of Transplantation   15 ( 1 )   155 - 160   2015.1

Transdisciplinary Approach for Sarcopenia. Clinical significance of sarcopenia in the patients with chronic liver disease Reviewed

Ken Shirabe, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, shinji itoh, Kazuki Takeishi, Takeo Toshima, Kohichi Kimura, Yoshihiro Matsumoto, Yuki Bekki, Daisuke Imai, Yoichi Yamashita, Hirofumi Kawanaka, Yoshihiko Maehara

Clinical calcium   24 ( 10 )   1493 - 1499   2014.10

Characteristic risk factors in cirrhotic patients for posthepatectomy complications Comparison with noncirrhotic patients Reviewed

shinji itoh, Hideaki Uchiyama, Hirofumi Kawanaka, Takahiro Higashi, Akinori Egashira, Daihiko Eguchi, Toshiro Okuyama, Masahiro Tateishi, Daisuke Korenaga, Kenji Takenaka

American Surgeon   80 ( 2 )   166 - 170   2014.2

Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma Reviewed

shinji itoh, Ken Shirabe, Yoshihiro Matsumoto, Shohei Yoshiya, Jun Muto, Norifumi Harimoto, Yo Ichi Yamashita, Toru Ikegami, Tomoharu Yoshizumi, Akihiro Nishie, Yoshihiko Maehara

Annals of Surgical Oncology   21 ( 9 )   3063 - 3068   2014.1

[Experience of 2013 Japan Exchange Fellow of the Japan Surgical Society and the American College of Surgeons]. Reviewed

shinji itoh

Nihon Geka Gakkai zasshi   115 ( 2 )   113 - 115   2014.1

Tape-guided pure laparoscopic hepatectomy for laterally located tumors A technique to yield an appropriate tumor-free surgical margin and to make parenchymal transection easier Reviewed

Hideaki Uchiyama, Kazutoyo Morita, shinji itoh, Kenji Takenaka

Journal of the American College of Surgeons   219 ( 3 )   2014.1

Small upper midline incision for living donor hemi-liver graft procurement in adults Reviewed

Toru Ikegami, Ken Shirabe, Yo Ichi Yamashita, Tomoharu Yoshizumi, Norifumi Harimoto, Kazuki Takeishi, Eiji Tsujita, shinji itoh, Yoshihiko Maehara

Journal of the American College of Surgeons   219 ( 3 )   2014.1

Preemptive thoracic drainage to eradicate postoperative pulmonary complications after living donor liver transplantation Reviewed

Daisuke Imai, Toru Ikegami, Takeo Toshima, Tomoharu Yoshizumi, Yo Ichi Yamashita, Mizuki Ninomiya, Norifumi Harimoto, shinji itoh, Hideaki Uchiyama, Ken Shirabe, Yoshihiko Maehara

Journal of the American College of Surgeons   219 ( 6 )   1134 - 1142.e2   2014.1

Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension Reviewed

Hirofumi Kawanaka, Tomohiko Akahoshi, shinji itoh, Tomohiro Iguchi, Norifumi Harimoto, Hideaki Uchiyama, Tomoharu Yoshizumi, Ken Shirabe, Kenji Takenaka, Yoshihiko Maehara

Journal of the American College of Surgeons   219 ( 5 )   865 - 874   2014.1

Long-term favorable surgical results of laparoscopic hepatic resection for hepatocellular carcinoma in patients with cirrhosis A single-center experience over a 10-year periods Reviewed

Yo Ichi Yamashita, Tetsuo Ikeda, Takeshi Kurihara, Yoshihiro Yoshida, Kazuki Takeishi, shinji itoh, Norifumi Harimoto, Hirofumi Kawanaka, Ken Shirabe, Yoshihiko Maehara

Journal of the American College of Surgeons   219 ( 6 )   1117 - 1123   2014.1

Outcomes of emergency surgery for acute abdomen in dialysis patients Experience of a single community hospital Reviewed

Takahiro Tomino, Hideaki Uchiyama, shinji itoh, Takahiro Higashi, Ai Edagawa, Akinori Egashira, Daihiko Eguchi, Hirofumi Kawanaka, Toshiroh Okuyama, Masahiro Tateishi, Daisuke Korenaga, Kenji Takenaka

Surgery Today   44 ( 4 )   690 - 695   2014

Reduced-dose telaprevir-based triple antiviral therapy for recurrent hepatitis C after living donor liver transplantation Reviewed

Toru Ikegami, Tomoharu Yoshizumi, Masaki Kato, Satomi Yamamoto, Takasuke Fukuhara, Yoshiharu Matsuura, Shota Nakamura, shinji itoh, Ken Shirabe, Yoshihiko Maehara

Transplantation   98 ( 9 )   994 - 999   2014

Pure laparoscopic partial hepatectomy using a newly developed vessel sealing device, BiClamp Reviewed

Hideaki Uchiyama, shinji itoh, Takahiro Higashi, Daisuke Korenaga, Kenji Takenaka

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques   23 ( 3 )   2013.6

局所進行肝細胞癌に対する薬物療法後の肝切除の意義 Invited

伊藤心二、萱島寛人、森田和豊、長尾吉泰、栗原　健、吉屋匠平、冨野高広、小斉侑希子、利田賢哉、中山湧貴、原田　昇、吉住朋晴

第123回日本外科学会定期学術集会  2023.4 

第109回日本消化器病学会総会

伊藤心二、吉屋匠平、吉住朋晴

第109回日本消化器病学会総会  2023.4 

肝細胞癌に対する腹腔鏡手術のインパクト

伊藤心二、森田和豊、長尾吉泰、栗原　健、冨野高広、小斉侑希子、原田　昇、吉住朋晴

第35回日本内視鏡外科学会総会  2022.12 

Intermediate stage肝細胞癌に対する肝切除の意義 Invited

伊藤心二、森田和豊、萱島寛人、長尾吉泰、吉屋匠平、栗原　健、冨野高広、小斉侑希子、原田　昇、吉住朋晴

第84回日本臨床外科学会総会  2022.11 

進行肝細胞癌における外科治療の意義 Invited

伊藤心二、森田和豊、萱島寛人、長尾吉泰、吉屋匠平、栗原　健、冨野高広、小斉侑希子、原田　昇、吉住朋晴

第84回日本臨床外科学会総会  2022.11 

Intermediate stage肝細胞癌における外科治療の意義

伊藤心二、原田　昇、吉住朋晴

第20回日本消化器外科学会大会(JDDW2022)  2022.10 

更なる予後向上を目指した進行肝細胞癌に対する集学的治療における外科治療の役割 Invited

伊藤心二、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、森田和豊、原田　昇、吉住朋晴

第60回日本癌治療学会学術集会  2022.10 

Multidisciplinary treatment in HCC: Impact of surgical intervention after systemic therapy

Shinji Itoh, Katsuya Toshida, Takahiro Tomiyama, Yukiko Kosai, Takahiro Tomino, Takeshi Kurihara, Yoshihiro Nagao, Kazutoyo Morita, Noboru Harada, Tomoharu Yoshizumi

2022.7 

肝細胞癌における集学的治療の一環と しての外科治療の意義

伊藤心二、吉住朋晴

第58回日本肝臓学会総会  2022.6 

Multidisciplinary treatment in HCC: Impact of surgery after multi-molecular target agent

Shinji Itoh, Katsuya Toshida, Takahiro Tomiyama, Akinari Morinaga, Yukiko Kosai, Takahiro Tomino, Takeshi Kurihara, Yoshihiro Nagao, Kazutoyo Morita, Noboru Harada, Tomoharu Yoshizumi

The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery  2022.6 

進行肝細胞癌に対する集学的治療における外科治療の意義

伊藤心二、森　正樹、吉住朋晴

第108回日本消化器病学会総会  2022.4 

肝細胞癌に対する生体肝移植における腫瘍内類洞様血管構造の意義 Invited

伊藤心二、原田　昇、戸島剛男、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、森田和豊、森　正樹、吉住朋晴

第83回日本臨床外科学会総会  2021.11 

原発性肝癌における癌代謝を反映するPET-CTと腫瘍免疫との関係

伊藤心二、吉住朋晴、森　正樹

第25回日本肝臓学会大会  2021.11 

肝胆膵悪性腫瘍の治療と最近の話題 Invited

伊藤心二、沖　英次、森　正樹、吉住朋晴

第59回日本癌治療学会  2021.10 

肝細胞癌におけるレンバチニブ投与におけるフェロトーシスの役割

伊藤心二、吉住朋晴、伊勢田憲史、原田　昇、森　正樹

第80回日本癌学会学術総会  2021.9 

Future perspectives of multidisciplinary treatment in HCC: Association with immune microenvironment

2021.7 

進行肝細胞癌に対する薬物療法と外科治療を中心とした集学的治療

伊藤心二、吉住朋晴、伊勢田憲史、利田賢哉、冨山貴央、森永哲成、島垣智成、王　歓林、栗原　健、長尾吉泰、戸島剛男、原田　昇、森　正樹

第57回日本肝癌研究会  2021.7 

肝悪性疾患における肝移植医療の適応拡大に向けた展望

伊藤心二、吉住朋晴、伊勢田憲史、冨山貴央、森永哲成、島垣智成、王　歓林、栗原　健、長尾吉泰、戸島剛男、原田　昇、森　正樹

第39回日本肝移植学会  2021.6 

肝細胞癌集学的治療における層別化治療にむけた展開

伊藤心二、吉住朋晴、森　正樹

第57回日本肝臓学会総会  2021.6 

肝細胞癌に対するストレス応答蛋白Nrf2と腫瘍免疫，がん代謝との関連

伊藤心二、吉住朋晴、森　正樹

第107回日本消化器病学会総会  2021.4 

進行肝細胞癌に対する分子標的治療における手術療法の役割

伊藤心二、吉住朋晴、栗原　健、島垣智成、王　歓林、長尾吉泰、戸島剛男、原田　昇、森　正樹

第121回日本外科学会定期学術集会  2021.4 

肝細胞癌における微小環境下での腫瘍免疫とがん代謝の意義

伊藤心二、吉住朋晴、伊勢田憲史、冨山貴央、森永哲成、下川雅弘、島垣智成、王　歓林、栗原　健、長尾吉泰、戸島剛男、原田　昇、森　正樹

第23回日本肝がん分子標的治療研究会  2021.1 

九州大学における「肝移植の醍醐味」 Invited

伊藤心二、吉住朋晴、伊勢田憲史、冨山貴央、森永哲成、湯川恭平、小斉侑希子、井口詔一、吉屋匠平、長尾吉泰、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第38回日本肝移植学会  2020.12 

障害肝に対する残肝を考慮したICG蛍光イメージングによる腹腔鏡下肝切除

伊藤心二、吉住朋晴、栗原　健、王　歓林、島垣智成、吉屋匠平、長尾吉泰、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第56回日本肝癌研究会  2020.12 

DAA治療後の肝細胞癌に対する肝切除の意義

伊藤心二、吉住朋晴、栗原　健、吉屋匠平、長尾吉泰、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第75回日本消化器外科学会総会  2020.12 

肝胆膵悪性腫瘍における宿主および腫瘍免疫の意義とストレス応答の役割 Invited

伊藤心二

第31回日本消化器癌発生学会  2020.11 

原発性肝癌における腫瘍免疫と癌代謝との関係

伊藤心二、吉住朋晴、湯川恭平、伊勢田憲史、冨山貴央、森永哲成、島垣智成、王　歓林、栗原　健、長尾吉泰、戸島剛男、原田　昇、森　正樹

第31回日本消化器癌発生学会  2020.11 

肝細胞癌における免疫回避調節因子CMTM6の意義

伊藤心二、吉住朋晴、森　正樹

2020.11 

肝細胞癌における腫瘍免疫の意義と腫瘍内血管構築との関係

伊藤心二、吉住朋晴、森　正樹

第56回日本肝臓学会学術集会  2020.8 

肝臓外科における腹腔鏡下系統的肝切除の役割

伊藤心二、吉住朋晴、吉屋匠平、長尾吉泰、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第120回日本外科学会定期学術集会  2020.8 

肝細胞癌（5cm以下、単発）における肝部分切除術と亜区域切除術の選択に関する検討

伊藤心二、吉住朋晴 、吉屋匠平、長尾吉泰、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第81回日本臨床外科学会学術集会  2019.11 

肝細胞癌に対する腫瘍免疫と腫瘍内血管構築との関係

伊藤心二、湯川恭平、伊勢田憲史、冨山貴央、森永哲成、小斉侑希子、井口詔一、 吉屋匠平、武石一樹、戸島剛男、原田　昇、池上　徹、吉住朋晴、森　正樹

第30回日本消化器癌発生学会  2019.11 

肝移植外科医へのリクルート Invited

伊藤心二、吉住朋晴、伊勢田憲史、冨山貴央、森永哲成、湯川恭平、小斉侑希子、井口詔一、吉屋匠平、長尾吉泰、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第55回日本移植学会総会  2019.10 

肝臓外科領域におけるフレイルの意義

伊藤心二、吉住朋晴、栗原　健、吉屋匠平、間野洋平、武石一樹、原田　昇、池上　徹、副島雄二、森　正樹

第74回日本消化器外科学会総会  2019.7 

Recent treatment strategies for HCC -non-surgical treatment, resection and transplantation-

Itoh S, Yoshizumi T, Imai D, Yoshiya S, Takeishi K, Harada N, Ikegami T, Mori M

The 31st Meeting of Japanese Society of Hepato-Biliary-Pancreatic Sugery  2019.6 

肝臓外科における原発性肝癌に対する骨格筋量と免疫栄養指数の意義-サルコペニア判定基準を用いた解析-

伊藤心二、原田　昇、吉住朋晴

第55回日本肝臓学会学術集会  2019.5 

肝移植周術期における呼吸器合併症対策

伊藤心二、今井大祐、栗原　健、吉屋匠平、間野洋平、武石一樹、原田　昇、池上　徹、副島雄二、吉住朋晴

第31回日本外科感染症学会総会学術集会  2018.11 

肝細胞癌に対する外科治療成績向上のための戦略

伊藤心二、栗原　健、吉屋匠平、間野洋平、武石一樹、原田　昇、池上　徹、副島雄二、吉住朋晴

第80回日本臨床外科学会学術集会  2018.11 

肝細胞癌における腫瘍免疫を反映する新たなバイオマーカーの探求

伊藤心二、吉住朋晴、前原喜彦

第54回日本肝臓学会学術集会  2018.6 

肝細胞癌に対する九大基準による生体肝移植の適応拡大

伊藤心二、吉住朋晴、別城悠樹、間野洋平、本村貴志、戸島剛男、原田　昇、池上　徹、副島雄二、前原喜彦

第36回日本肝移植研究会  2018.5 

肝細胞癌における末梢血液分画比を用いた腫瘍免疫に関する新たなバイオマーカー

伊藤心二

第22回日本がん分子標的治療学会学術集会  2018.5 

肝細胞癌に対する腫瘍免疫と微小環境をターゲットとした新規治療法の探求

伊藤心二、吉住朋晴 、前原喜彦

第104回日本消化器病学会総会  2018.4 

周術期における肝切除合併症回避のための治療戦略

伊藤心二、吉住朋晴、播本憲史、大平将史、本村貴志、間野洋平、戸島剛男、原田　昇、池上　徹、副島雄二、池田哲夫、前原喜彦

第79回日本臨床外科学会総会  2017.11 

Lymphocyte-to-monocyte ratio is associated with PD-L1 expression on tumor progression in hepatocellular carcinoma

Itoh S, Yoshizumi T, Shimokawa M, Mano Y, Motomura T, Toshima T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y

2017.11 

Relationship between skeletal muscle mass assessed by computed tomography and muscle strength in patients with liver disease. International conference

Itoh S, Yoshizumi T, Nagatsu A, Motomura T, Harada N, Harimoto N, Ikegami T, Soejima Y, Ikeda T, Kamishima T, Maehara Y

40th World Congress of the International College of Surgeons  2016.10 

Surgical treatment of hepatocellular carcinoma with macroscopic portal venous tumor thrombus

Itoh S, Yoshizumi T, Harimoto N, Kimura K, Okabe H, Harada N, Ikegami T, Uchiyama H, Ikeda T, Maehara Y

2016.7 

Phase I study of sorafenib in combination with uracil-tegafur in patients with unresectable advanced hepatocellular carcinoma in Japan International conference

Shinji Itoh, Ken Shirabe, Koichi Kimura, Hironao Okabe, Norifumi Harimoto, Toru Ikegami, Hideaki Uchiyama, Tomoharu Yoshizumi, Tetsuo Ikeda, Yoshihiko Maehara

ESMO Asia 2015 Congress  2015.12 

EOB-MRIを用いた新たな肝予備能評価の意義

伊藤 心二

第101回日本消化器病学会総会  2015.4 

肝細胞癌におけるMRI所見と癌微小環境との関連についての検討

伊藤心二、冨野高広、利田賢哉 、伊勢田憲史、吉屋匠平、戸島剛男、小田義直、吉住朋晴

第82回日本癌学会学術集会  2023.9 

肝内胆管癌における高齢者に対する肝切除の治療成績

伊藤心二、吉屋匠平、冨野高広、利田賢哉、原田　昇、吉住朋晴

第59回日本胆道学会学術集会  2023.9 

肝細胞癌に対する免疫複合療法と外科治療のコンビネーション

伊藤心二、利田賢哉、長尾吉泰、吉屋匠平、冨野高広、下川雅弘、小斉侑希子、筒井由梨子、中山湧貴、原田　昇、吉住朋晴

第59回日本肝癌研究会  2023.7 

Comparison of background characteristics of patients receiving lenvatinib vs atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma International conference

Shinji Itoh, Masafumi Ikeda, Daisuke Onozuka, Ryosuke Tateishi, Tatsuya Yamashita, Takuji Okusaka, Naoya Kato, Junji Furuse, Masatoshi Kudo

APPLE2023  2023.7 

肝細胞癌に対する肝切除術における微小脈管侵襲の意義

伊藤心二、長尾吉泰、吉屋匠平、冨野高広、下川雅弘、小斉侑希子、筒井由梨子、利田賢哉、中山湧貴、原田　昇、吉住朋晴

第59回日本肝癌研究会  2023.7 

当院における生体肝移植術後胆管合併症の現状

伊藤心二、原田　昇、戸島剛男、長尾吉泰、吉屋匠平、冨野高広、下川雅弘、小斉侑希子、筒井由梨子、利田賢哉、中山湧貴、吉住朋晴

第41回日本肝移植学会学術集会  2023.6 

基礎と臨床から紐解くこれからの進行肝細胞癌治療 Invited

伊藤心二

第27回日本がん分子標的治療学会学術集会  2024.6 

複合免疫療法時代における肝細胞癌の集学的治療戦略 Invited

伊藤心二

第48回日本外科系連合学会学術集会  2023.6 

薬物療法と外科の協働による肝細胞癌の治療戦略

伊藤心二、原田　昇、吉住朋晴

第59回日本肝臓学会総会  2023.6 

当院でのロボット支援下肝切除術の治療成績

伊藤心二、吉屋匠平、萱島寛人、長尾吉泰、冨野高広、小斉侑希子、原田　昇、吉住朋晴

第15回日本ロボット外科学会学術集会  2023.2 

切除不能肝細胞癌における薬物療法に関する 前向き観察研究(PRISM 試験)

伊藤心二、池田公史、建石良介、山下竜也、奥坂拓志、加藤直也、古瀬純司、工藤正俊

第27回日本肝がん分子標的治療研究会  2023.1 

当院におけるロボット支援下肝切除術の導入

伊藤心二、森田和豊、長尾吉泰、栗原　健、冨野高広、小斉侑希子、原田　昇、吉住朋晴

第35回日本内視鏡外科学会総会  2022.12 

当院でのロボット支援下肝切除術の導入

伊藤心二、吉屋匠平、萱島寛人、長尾吉泰、冨野高広、小斉侑希子、原田　昇、吉住朋晴

第16回肝臓内視鏡外科研究会  2022.11 

肝細胞癌に対する集学的治療と低侵襲手術

伊藤心二、森田和豊、長尾吉泰、栗原　健、冨野高広、小斉侑希子、原田　昇、吉住朋晴

第32回九州内視鏡・ロボット外科手術研究会  2022.9 

生体肝移植ドナーにおける新たな手術手技

伊藤心二、原田　昇、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、戸島剛男、森田和豊、吉住朋晴

第40回日本肝移植学会学術集会  2022.7 

肝細胞癌に対する薬物療法における骨格筋量が予後へ及ぼす影響

伊藤心二、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、森田和豊、原田　昇、吉住朋晴

第24回日本肝がん分子標的治療研究会  2022.6 

個別化治療を目指した肝細胞癌における微小環境のバイオマーカーの探求

伊藤心二、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、森田和豊、原田　昇、吉住朋晴

第24回日本肝がん分子標的治療研究会  2022.6 

進行肝細胞癌に対する集学的治療における外科治療の意義

伊藤心二、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、森田和豊、原田　昇、吉住朋晴

第58回日本肝癌研究会  2022.5 

個別化治療を目指した肝細胞癌における微小環境のバイオマーカーの探求

伊藤心二、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、森田和豊、原田　昇、森　正樹、吉住朋晴

第122回日本外科学会定期学術集会  2022.4 

膵頭十二指腸術後の膵液漏に対する超音波内視鏡下膵管ドレナージ

伊藤心二、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、森田和豊、原田　昇、吉住朋晴

第58回日本腹部救急医学会総会  2022.3 

肝胆膵外科医における胆道癌へのゲノム医療への関わり

伊藤心二、吉住朋晴、森　正樹

第57回日本胆道学会学術集会  2021.10 

生体肝移植レシピエント手術における新たな手術手技- 肝動脈処理の工夫-

伊藤心二、原田　昇、戸島剛男、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、森田和豊、森　正樹、吉住朋晴

第57回日本移植学会  2021.9 

進行肝細胞癌に対する薬物療法における外科治療の役割

伊藤心二、吉住朋晴、利田賢哉、冨山貴央、森永哲成、小斉侑希子、冨野高広、栗原　健、長尾吉泰、森田和豊、原田　昇、森　正樹

第24回日本肝がん分子標的治療研究会  2021.8 

腫瘍内血管から見た肝細胞癌における新規概念：腫瘍内類洞様血管構造の意義

伊藤心二、吉住朋晴、伊勢田憲史、冨山貴央、森永哲成、島垣智成、王　歓林、栗原　健、長尾吉泰、戸島剛男、原田　昇、森　正樹

第30回日本がん転移学会学術集会  2021.7 

肝細胞癌に対する腫瘍免疫に着目した個別化治療に向けた展開

伊藤心二、吉住朋晴、伊勢田憲史、島垣智成、王　歓林、栗原　健、長尾吉泰、戸島剛男、原田　昇、森　正樹

第57回日本肝癌研究会  2021.7 

Effect of indocyanine green fluorescence navigation in laparoscopic liver resection: a single center experience and propensity score matching study

Shinji Itoh, Tomoharu Yoshizumi, Takeshi Kurihara, Tomonari Shimagaki, Huanlin Wang, Yoshihiro Nagao, Takeo Toshima, Noboru Harada, Masaki Mori

2021.6 

肝細胞癌における腫瘍微小環境下でのPD-L1調節因子CMTM6の生物学的意義

伊藤心二、森　正樹

第25回日本がん分子標的治療学会  2021.5 

Impact of frailty on short and long-term outcomes in patients after liver resection

Shinji Itoh, Tomoharu Yoshizumi, Takeshi Kurihara, Shohei Yoshiya, Yoshihiro Nagao, Kazuki Takeishi, Takeo Toshima, Noboru Harada, Toru Ikegami, Masaki Mori

2021.2 

肝臓外科領域におけるフレイルの意義 Invited

伊藤心二、吉住朋晴、島垣智成、王　歓林、栗原　健、長尾吉泰、戸島剛男、原田　昇、森　正樹

第82回日本臨床外科学会学術集会  2020.10 

肝細胞癌おける8-OHdGとDNA修復酵素OGG1発現の意義

伊藤心二、湯川恭平、吉住朋晴、長尾吉泰、武石一樹、戸島剛男、原田　昇、池上　徹、孝橋賢一、小田義直、森　正樹

第72回日本酸化ストレス学会学術集会  2020.10 

原発性肝癌に対する肝切除術後早期の骨格筋量変化の意義

伊藤心二、吉住朋晴、森　正樹

第56回日本肝臓学会学術集会  2020.8 

肝細胞癌に対する腫瘍免疫の意義

伊藤心二、吉住朋晴、湯川恭平、伊勢田憲史、冨山貴央、森永哲成、小斉侑希子、井口詔一、吉屋匠平、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第22回日本肝がん分子標的治療研究会  2020.1 

障害肝併存肝細胞癌に対する傾向スコアを用いた開腹vs腹腔鏡下肝切除術の検討

伊藤心二、吉住朋晴、吉屋匠平、長尾吉泰、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第32回日本内視鏡外科学会総会  2019.12 

生体肝移植症例における肝線維化マーカーM2BPGiの意義

伊藤心二、吉住朋晴、今井大祐、吉屋匠平、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第55回日本移植学会総会  2019.10 

肝内胆管癌における術前栄養・炎症マーカーの意義に関する検討

伊藤心二、吉住朋晴、今井大祐、吉屋匠平、武石一樹、原田　昇、池上　徹、副島雄二、森　正樹

第55回日本胆道学会学術集会  2019.10 

障害肝に対する残肝を考慮した腹腔鏡下肝切除

伊藤心二、吉住朋晴、冨山貴央、伊勢田憲史、森永哲成、井口詔一、湯川恭平、小斉侑希子、吉屋匠平、長尾吉泰、武石一樹、戸島剛男、原田　昇、池上　徹、森　正樹

第14回肝癌ナビゲーション研究会  2019.9 

膵癌における免疫栄養指数の意義ー多施設における解析ー

伊藤心二、辻田英司、吉住朋晴、福澤謙吾、杉町圭史、二宮瑞樹、前田貴司、梶山　潔、足立英輔、内山秀昭、宇都宮徹、原田　昇、池上　徹、副島雄二、森　正樹

第50回日本膵臓学会大会  2019.7 

障害肝での肝細胞癌に対する傾向スコアを用いた開腹vs腹腔鏡下肝切除の比較検討

伊藤心二、吉住朋晴、栗原　健、吉屋匠平、間野洋平、武石一樹、原田　昇、池上　徹、副島雄二、森　正樹

第55回日本肝癌研究会  2019.7 

肝細胞癌における肝部分切除術と亜区域切除術の選択に関する検討

伊藤心二、吉住朋晴、栗原　健、吉屋匠平、間野洋平、長尾吉泰、武石一樹、原田　昇、池上　徹、副島雄二、森　正樹

第119回日本外科学会　定期学術集会  2019.4 

腹腔鏡下肝切除の定型化に向けた取り組み

伊藤心二、吉住朋晴、栗原　健、吉屋匠平、間野洋平、長尾吉泰、武石一樹、原田　昇、池上　徹、副島雄二、森　正樹

第11回福岡県医学会総会  2019.2 

巨大肝腫瘍に対する我々の肝切除術

伊藤心二、吉住朋晴、伊勢田憲史、冨山貴央、森永哲成、湯川恭平、小斉侑希子、井口詔一、栗原　健、吉屋匠平、間野洋平、武石一樹、原田　昇、池上　徹、副島雄二、森　正樹

第40回九州肝臓外科研究会  2019.1 

左半腹臥位を用いた肝右葉前上、後区域領域における腹腔鏡下肝切除術

伊藤心二、吉住朋晴、池田哲夫、川﨑淳司、島垣智成、坂田一仁、下川雅弘、吉田佳弘、長津明久、本村貴志、原田　昇、播本憲史、池上　徹、副島雄二、前原喜彦

第10回肝臓内視鏡下外科研究会  2016.11 

腹腔鏡下肝切除の定型化に向けた取り組み

伊藤心二、吉住朋晴、栗原　健、吉屋匠平、間野洋平、武石一樹、原田　昇、池上　徹、副島雄二

第12回肝臓内視鏡外科研究会  2018.11 

非B非C肝細胞癌に対する肝切除成績およびHBc抗体との関連

伊藤心二、吉住朋晴、間野洋平、本村貴志、戸島剛男、原田　昇、播本憲史、池上　徹、副島雄二、前原喜彦

第15回日本消化器外科学会大会  2017.10 

Impact of lymphocyte-to-monocyte ratioon progression in hepatocellular carcinoma associated with PD-L1 expression

Itoh S, Yoshizumi T, Shimokawa M, Mano Y, Motomura T, Toshima T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y

2017.9 

トルバプタンを用いた肝切除術後における腹水発症予防の治療戦略

伊藤心二、吉住朋晴、間野洋平、本村貴志、戸島剛男、原田　昇、播本憲史、池上　徹、副島雄二、前原喜彦

第24回日本門脈圧亢進症学会総会  2017.9 

肝予備能が低下した肝硬変併存深部肝細胞癌に対する手術手技- Split Enucleation -

伊藤心二、吉住朋晴、池上　徹、長津明久、本村貴志、間野洋平、原田　昇、播本憲史、副島雄二、池田哲夫、前原喜彦

第71回手術手技研究会  2017.5 

The technical evolution for laparoscopic hepatectomy

2017.4 

肝細胞癌における代謝性疾患とB型肝炎既感染との関連に関する研究

伊藤心二、吉住朋晴、副島雄二、池上　徹、播本憲史、原田　昇、本村貴志、王　歓林、長津明久、吉田佳弘、下川雅弘、坂田一仁、島垣智成、川崎淳司、池田哲夫、前原喜彦

第103回日本消化器病学会総会  2017.4 

腹腔鏡下肝切除の進歩と高齢者肝細胞癌患者への適応拡大

伊藤心二、吉住朋晴、池田哲夫、王　歓林、長津明久、本村貴志、原田　昇、播本憲史、池上　徹、副島雄二、前原喜彦

第29回日本内視鏡外科学会総会  2016.12 

門脈内腫瘍栓を伴う肝細胞癌に対する外科治療を中心とした治療戦略

伊藤心二、吉住朋晴、副島雄二、池上　徹、播本憲史、原田　昇、本村貴志、王　歓林、長津明久、吉田佳弘、下川雅弘、坂田一仁、島垣智成、川﨑淳司、池田哲夫、前原喜彦

第78回日本臨床外科学会総会  2016.11 

ABO血液型不適合生体肝移植の成績向上に向けた我々の戦略

伊藤心二、吉住朋晴、副島雄二、池上　徹、播本憲史、原田　昇、本村貴志、王　歓林、長津明久、吉田佳弘、下川雅弘、坂田一仁、島垣智成、池田哲夫、前原喜彦

第52回日本移植学会総会  2016.9 

B型肝炎既往感染による肝細胞癌発癌・悪性度への影響に関する研究

伊藤心二、吉住朋晴、副島雄二、池上　徹、播本憲史、原田　昇、本村貴志、王　歓林、長津明久、吉田佳弘、下川雅弘、坂田一仁、島垣智成、川崎淳司、池田哲夫、前原喜彦

第27回日本消化器癌発生学会総会  2016.9 

生体肝移植レシピエントにおける新しい肝門部処理〜New hilar dissection〜

伊藤心二、吉住朋晴、池上　徹、副島雄二、播本憲史、原田　昇、本村貴志、長津明久、王　歓林、前原喜彦

第34回日本肝移植研究会  2016.7 

Surgical treatment of hepatocellular carcinoma with macroscopic portal venous tumor thrombus

Itoh S, Yoshizumi T, Harimoto N, Kimura K, Okabe H,Harada N, Ikegami T, Uchiyama H, Ikeda T, Maehara Y

2016.6 

門脈内腫瘍栓を有する進行肝癌に対する外科切除を中心とした治療成績

伊藤心二、調　憲 、播本憲史、下川雅弘、坂田一仁、吉田佳弘、冨野高広、今井大祐、別城悠樹、王　歓林、木村光一、岡部弘尚、池上　徹、内山秀昭、吉住朋晴、池田哲夫、前原喜彦

第102回日本消化器病学会総会  2016.4 

門脈内腫瘍栓を有する進行肝癌に対する外科治療成績と分子機序に基づいた新しい治療戦略

伊藤心二、調　憲 、播本憲史、下川雅弘、坂田一仁、吉田佳弘、冨野高広、今井大祐、別城悠樹、王　歓林、木村光一、岡部弘尚池上　徹、内山秀昭、吉住朋晴、池田哲夫、前原喜彦

第116回日本外科学会定期学術集会  2016.4 

肝細胞癌に対する腹腔鏡下肝切除術の治療成績

伊藤心二、池田哲夫、坂田一仁、下川雅弘、吉田佳弘、今井大祐、別城悠樹、木村光一、岡部弘尚、播本憲史、池上　徹、内山秀昭、吉住朋晴、調　憲、前原喜彦

第28回日本内視鏡外科学会総会  2015.12 

当教室における血液型不適合生体肝移植の長期成績

伊藤 心二

第51回日本移植学会総会  2015.10 

術前肝細胞癌の診断で術後混合型肝癌と診断された症例に対する生体肝移植の成績

伊藤心二、調　　憲、栗原　健、吉田佳宏、今井大祐、別城悠樹、王　歓林、木村光一、松本佳大、武石一樹、播本憲史、山下洋市、池上　徹、吉住朋晴、川中博文、池田哲夫、前原喜彦

第23回日本消化器関連学会週間（第13回日本消化器外科学会大会）  2015.10 

肝細胞癌に対する生体肝移植術における体内組成評価(骨格筋/内脂肪比)の意義に関する研究

伊藤 心二

第70回日本消化器外科学会総会  2015.7 

腹腔鏡下肝切除術の進歩

伊藤 心二

第105回日本消化器学会九州支部例会  2015.6 

肝細胞癌に対する生体肝移植術におけるBody compositionの意義に関する研究

伊藤 心二

第27回日本肝胆膵外科学会総会  2015.6 

生体肝移植レシピエントの肝十二指腸靭帯剥離における結紮を用いない肝動脈処理による動脈解離予防効果と剥離手技の定型化

伊藤 心二

第69回手術手技研究会  2015.5 

生体肝移植レシピエントの肝十二指腸靭帯剥離における結紮を用いない肝動脈処理による動脈解離予防効果と剥離手技の定型化

伊藤 心二

第33回日本肝移植研究会  2015.5 

EOB-MRIおよび3D-CT volumetryを用いた新たな肝予備能評価

伊藤 心二

第115回日本外科学会定期学術集会  2015.4 

Impact of the Inflammatory Marker Soluble CD163 for Patients with Hepatocellular Carcinoma following Hepatic Resection

2014.11 

大腸癌肝転移に対する腹腔鏡下肝切除術の有用性

伊藤 心二

第27回日本内視鏡外科学会総会  2014.10 

日本肝移植学会

日本門脈圧亢進症学会

日本酸化ストレス学会

日本腹部救急医学会

日本外科感染症学会

日本消化器癌発生学会

日本臨床外科学会

日本がん転移学会

日本がん分子標的治療学会

日本内視鏡外科学会

日本癌学会

日本癌治療学会

日本消化器病学会

日本移植学会

日本膵臓学会

日本胆道学会

日本肝臓学会

日本肝胆膵外科学会

日本消化器外科学会

日本外科学会

American College of Surgeons

Councilor   Domestic

2022.5 - Present   

Councilor   Domestic

2022.4 - Present   

Councilor   Domestic

2022.3 - Present   

Councilor   Domestic

2022.1 - Present   

Councilor   Domestic

2021.1 - Present   

日本肝がん分子標的治療研究会   世話人   Domestic

2021.1 - Present   

Councilor   Domestic

2020.6 - Present   

Councilor   Domestic

2019.6 - Present   

Councilor   Domestic

2019.1 - Present   

日本肝臓学会   西部支部評議員   Domestic

2017.11 - Present   

日本消化器病学会   九州支部評議員   Domestic

2017.6 - Present   

Steering committee member   Domestic

2013.11 - Present   

日本消化器癌発生学会   財務委員   Domestic

2013.11 - Present   

Councilor   Domestic

2011.11 - Present   

Councilor   Domestic

2009.6 - Present   

Screening of academic papers

Role(s)： Peer review

2018

Screening of academic papers

Role(s)： Peer review

2017

COSMOS試験

2021.5

REPLACEMENT試験

2020.12

PRISM試験

2020.6

HAMRET試験

2020.2

KSCC（日本） 

肝癌における新規細胞死フェロトーシス機序解明と革新的治療法への開発

Grant number：19K09198  2019 - 2021

日本学術振興会  科学研究費助成事業  基盤研究(C)

ストレス応答性転写因子による代謝リプログラミングを標的とした肝癌への革新的治療

Grant number：16K10576  2016 - 2018

日本学術振興会  科学研究費助成事業  基盤研究(C)

治療抵抗性肝細胞癌おけるマイクロRNAの機能解析と新規治療への展開

Grant number：26893191  2014 - 2015

日本学術振興会  科学研究費助成事業  研究活動スタート支援

2018  Class Teacher 

2017  Class Teacher 

2016  Class Teacher 

2015  Class Teacher 

2014  Class Teacher 

Preceptor

The Japan Society of Hepatology（JSH）

Specialist

The Japanese Society of Gastroenterology（JSGE）

Certifying physician

The Japan Society for Endoscopic Surgery（JSES）

Preceptor

The Japanese Society of Gastroenterology（JSGE）

Specialist

The Japanese Society of Gastroenterological Surgery

Preceptor

The Japanese Society of Gastroenterological Surgery

Certifying physician

Japan Surgical Society（JSS）

Specialist

Japan Surgical Society（JSS）

Preceptor

Japan Surgical Society（JSS）